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The aim of this thesis is to develop Surface Plasmon Resonance (SPR) methods that 
improve biosensing performance, in particular the sensitivity and selectivity of the analysis 
and their adaptation for biomedical applications to samples with complex background.  
This is of significant importance in translating the biosensor technologies to deliver the 
same results as the conventional methods but in a more accessible, efficient, and 
economical manner. The first study exploited SPR as a DNA biosensor for the detection of 
Malaria Plasmodium falciparum parasite with the hybridization chain reaction (HCR), 
which resulted in the formation of self-assembled target DNA nanostructures for signal 
enhancement. The sensitivity was further improved by using gold nanoparticles (AuNPs) 
for additional signal amplification. Tests with human blood plasma indicated the results 
were comparable to analyses in buffer, despite noticeable non-specific binding from the 
plasma. The concern of non-specific binding was systematically investigated in the second 
 x 
study where an antifouling surface consists of supported lipid bilayer membranes (SLBs) 
and protein A was developed for detection of trace amount of proteins in undiluted human 
serum. Specifically, cholera toxin (CT) spiked into the serum was used as the target, and 
advanced interface was further extended to immunosensing of immunoglobulin G (IgG). 
In the third study, SPR biosensor was employed in combination of bright field microscopy 
to characterize cellular apoptosis. HeLa cells undergoing apoptosis induced by hydrogen 
peroxide (H2O2) were monitored by SPR and the signals were compared to microscopic 
analysis of the morphological changes. SPR study revealed a decreased signal as cell 
confluency decreases, with the rates increasing as H2O2 concentration increases. An 
abnormality was found at high concentrations when both apoptosis and necrosis were 
induced. A mathematical model was proposed to explain SPR response where a non-
uniform adsorbed layer was partially responsible. The significance of this thesis is that a 
number of high performing biosensing approaches have been developed and demonstrated. 
In addition to the advantages of SPR (e.g. label-free, real-time biomolecules binding, and 
portability), these methods have paved the way towards realizing effective sensing in 
biomedical research, especially in the early detection of infectious diseases and in the 
treatment of cancers. 
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 1 
 Motivation, Challenges and Introduction to SPR 
Biosensors for Biomedical Research 
 
 Medical and Clinical Diagnostics Processes 
Medical and clinical diagnostics is the practice of detecting, identifying and 
monitoring a disease or medical disorder. A diagnostic process begins when a patient 
experiences a health problem and engages with health care system. The processes consist 
of gathering and interpreting information and working diagnosis which includes physical 
exam and diagnostic testing.1 The diagnostic testing can be through clinical lab, medical 
imaging, and anatomy pathology where tissue samples are taken from a biopsy. Diagnostic 
testing is important for detecting infectious diseases such as tuberculosis, Malaria and HIV, 
as early detection helps in the patients’ treatment and eradication of the diseases.2 Most 
diagnostic techniques used for such diseases involves collecting patients’ bodily fluids such 
as blood and urine, then taking them to laboratory for series of tests. Common techniques 
includes immunoassays such as ELISA, colorimetric, microscopy, protein Western blot, 
rapid immunotechniques sticks, and nucleic acid based test; which are laborious, slow, less 
sensitive, and sometimes ineffective, and expensive.3 For more severe diseases like cancer, 
the diagnosis is more complicated that it requires more than blood lab tests or tissue 
samples test for the tumor biomarkers.4  In addition to tests, the diagnosis of cancers also 
include 1) physical exam for lumps and other abnormalities, 2) imaging tests such as 
computerized tomography (CT) scan, bone scan, magnetic resonance imaging (MRI), 
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positron emission tomography (PET) scan, ultrasound and X-ray, and 3) sample cells 
biopsy.5, 6  
Although many advanced and rapid diagnostic techniques for infectious diseases are 
being developed, an increased focus on customized and consumer-driven health care has 
also increased the demand for point of care diagnostic and home testing device kit which 
can take place of traditional laboratory-based testings.3 This refers to a technology where 
the bulky equipment is miniaturized into a portable size and integrated with a data 
processing for faster results analysis and transfer of data via a wireless communication. In 
the case of cancers diagnosis, while the current diagnostic techniques cannot be replaced, 
oncology studies can benefit from a simple bioanalysis techniques to detect cancer 
biomarkers or even in monitoring of cancer cells toxicity effects for new drugs 
development.7 
 Biosensors for Biomedical Applications 
Biosensors technology is actively researched in the medical field to diagnose 
infectious diseases and many types of cancers.8, 9 One of the advantages of biosensors is 
that the detection of target molecule is achievable in very low quantities, thus allowing 
early detection of diseases.10 A biosensor has been demonstrated to be working in vitro and 
in vivo environment for  a precise detection of disease biomarker.11 In another 
development, many strategies were attempted for biosensor platforms that are 
miniaturized,9 wearable,12 non-invasive,13 portable,14, 15 potential for point-of-care 
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testing,16, 17 connected to smart phones18 and integrated to the Internet-of-Things (IoT) data 
communication networks for continuous monitoring of patients conditions.19  
In clinical diagnosis, biosensors have been used for the detection and monitoring 
of various analytes, such as glucose, urea, lactate, cholesterol, and uric acid in biological 
samples including blood, serum and urine.20 Although many novel biosensors have been 
developed for research purposes, and while biosensing instruments can be easily found in 
labs, only two over-the-counter biosensors are available. Glucose meter is the best example 
of how biosensor contributes to a more effective healthcare, that patients can have 
immediate response to their medical condition without having to wait for lab results. For 
people who has diabetic condition, monitoring the glucose level in blood has become an 
important part in managing their life to avoid long-term complication. Today, technology 
trend of glucose meter is moving towards noninvasive and continuous glucose monitoring, 
both eliminate the need of drawing blood and provide real time measurement. Another 
successful biosensor is the pregnancy test kit using urine sample, which is affordable and 
easy to use. Most pregnancy test kit is a qualitative test; however, a quantitative type has 
already been available in the market, able to determine the weeks after conception. The 
glucose meter and pregnancy test show that it is feasible to produce biosensors that can 
directly impact the healthcare field. However, a lot more work has to be done to translate 
lab scale biosensors to a real world application21.  
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 Principles of Biosensors 
Biosensors are analytical devices that consist of a biological recognition element 
and a suitable transducer, usually coupled to an appropriate data processing system.22 Other 
than in the medical field, biosensors have also been used widely in other applications such 
as food quality assurance,23 agriculture, pharmaceutical, defense and environmental 
monitoring.24  
 
 
Figure 1.1 Schematic of biosensor 
 
As is depicted in Figure 1.1, the biological recognition element of a biosensor can 
be antibody, DNA, enzyme, or whole cell. Recognition elements can be immobilized on a 
sensor support or sensor surface using different methods such as entrapment, 
encapsulation, adsorption, and covalent attachment. The transducer then converts the 
physico-chemical change, due to the interaction of molecules with the receptor, into a 
measurable output signal.  The signal processing is the part of biosensor that process, 
amplify and quantify the transduced signal, before it is ready for display on the user 
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interface. Most transducers produce either optical or electrical signals that are usually 
proportional to the amount of the interaction between the analyte and its biorecognition 
element. The typical characteristics of biosensors are;24  
a) Selectivity: The ability of bioreceptors to detect the specific analyte in a mixture 
of sample and contaminants. For example; specific interaction of antibody with 
a particular antigen 
b) Reproducibility: The ability of the biosensor to generate identical responses for 
a duplicated experimental set-up. 
c) Stability: The degree of susceptibility to ambient disturbances in and around the 
biosensing system. 
d) Sensitivity: The minimum amount of analyte that can be detected by a biosensor 
defines its limit of detection (LOD) or sensitivity. 
e) Linearity: The attribute that shows the accuracy of the measured response (for 
a set of measurements with different concentrations of analyte) to a straight line 
 
Biosensors are most commonly classified based on the biorecognition element and 
the signal transduction. Based on the biological recognition element, biosensors have been 
classified into enzymatic, immunosensors, DNA biosensors, and whole-cell biosensors.25, 
26 Enzyme biosensors have been devised on immobilization methods, i.e. adsorption of 
enzymes by van der Waals forces, ionic bonding or covalent bonding. The commonly used 
enzymes for this purpose are oxidoreductases, polyphenol oxidases, peroxidases, and 
aminooxidases.27, 28 Immunosensors were established on the fact that antibodies have high 
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affinity towards their respective antigens, i.e. the antibodies specifically bind to pathogens 
or toxins, or interact with components of the host's immune system. The DNA biosensors 
were devised on the property that single-strand nucleic acid molecule is able to recognize 
and bind to its complementary strand in a sample. The interaction is due to the formation 
of stable hydrogen bonds between the two nucleic acid strands (i.e., hybridization). The 
most widely used whole-cell biosensors are the microbial and mammalian cells tissues, 
often used to study toxicity, carcinogenicity, and mutagenicity of the cells towards 
chemicals or drugs under investigation. 
Biosensors are also classified according to the transduction techniques; including 
electrochemical, optical, mass-based/ piezoelectric and thermal sensors.  Electrochemical 
and optical are the two types of detection methods frequently used in biosensors. In 
electrochemical detection technique, the direct conversion of a biological reaction to an 
electronic signal is measured. The most common techniques include cyclic voltammetry, 
chronopotentiometry, impedance spectroscopy and field-effect transistor. Electrochemical 
sensing usually requires a reference electrode, a counter or auxiliary electrode and a 
working electrode. The recognition element is commonly enzymes due to their specific 
binding capabilities and biocatalytic activity, but other elements are used such as 
antibodies, nucleic acids, cells and microorganism.22 
Optical biosensors are the most commonly reported class of biosensors, due to their 
advantages include high specificity, sensitivity, small size and cost effectiveness for the 
detection of wide range of analytes.29 Unlike electrochemical methods, optical detection 
allows a safe non-electrical sensing of biological elements and do not require reference 
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electrode, making it a simple construction. An optical biosensor usually is a compact device 
containing the biorecognition elements, combined with optical transducer system that 
produce a signal which is proportionate to the concentration of measured analytes.  
 
 Surface Plasmon Resonance (SPR) Biosensors 
SPR biosensors belong to the label-free optical biosensing technologies. Label-free 
assays measure the presence of analytes in their natural forms and the detected signal is 
directly by the interaction of the analytes with the transducer.30 For labeled assays, either 
analytes or biorecognition molecules are labeled with signaling tags, such as fluorophores 
fluorophore, quantum dot or radioisotope, and the optical signal is then generated by a 
colorimetric, fluorescent or luminescent methods.31 The label-free method is more 
preferred for biosensors due to its simplicity and shorter assay time, and has ability to 
perform measurements of molecular interaction in real-time, thus allowing continuous 
monitoring.32 For disease diagnostics purposes, a label-free detection provides more room 
for small molecular targets, which can be less accessible when a label tag is present. 
SPR biosensor has been successfully used for the detection of various analytes such 
as proteins,33 DNA,34 drugs,35 and microbials such as E. Coli,36 and bacteria.37 Because of 
the advantages offered by SPR method, particularly its versatility for detection of many 
analytes, label-free, real time monitoring, potential rapid response,38 the recent 
development of SPR focuses on more advance medical and healthcare applications. These 
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include disease biomarkers, 36 pharmaceutical research such as in drug development and 
drug delivery,39, 40 and development of portable SPR. 41, 42  
1.4.1 Principle of SPR Detection 
The SPR method is based on an optical measurement of a refractive index change 
associated with the binding of analyte molecules in a sample to the capture molecules 
immobilized on the SPR sensor surface.43 An SPR system is typically constructed with a 
light source, a prism, a sensor chip and a detector that measures the output of the reflected 
incident light (the Kretschmann Configuration, Figure 1.2).  This system is usually 
combined with a fluidic flow carrying the analyte to be reacted with the ligand immobilized 
on the sensor surface. In this method, a light source passes through a prism, reflects off the 
backside of the sensor chip surface and into a detector. At a certain incident angle, known 
as resonance angle, light is absorbed by the electrons in the metal film on the sensor chip 
causing them to resonate.  This resonating electron are also known as surface plasmons, 
regarded as an evanescent wave propagating along a metal-dielectric interface.44 This wave 
is evanescent meaning it decays exponentially the further it gets from the metal surface, 
providing a high surface sensitivity to the surrounding environment.  The depth of the 
evanescent wave which is useful for measurement is within 300 nm of the sensor surface.45 
The wavelength of the evanescent field is the same as the wavelength of the incident light 
at a total internal reflectivity (TIR) condition. 
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Figure 1.2 SPR Detection: Intensity profile and the shift of SPR angle 
 
 
With the metal layer acting as a resonator, a coupling can occur between the 
plasmon of the free electron in the metal and the bound electromagnetic field of the total 
internally reflected photons. Through the coupling, the energy from the photons is 
transferred into surface plasmons, resulting in an intensity lost in the reflected beam, which 
appears as a dark band. This can be seen as a drastic dip in the SPR reflectivity curve 
showing the resonance angle as the minimum angle.  The change in reflected light intensity 
or resonance angle is converted to SPR angle shift, q (Figure 1.3, edited from ref. 36 ). The 
shape and location of the SPR dip can be used to convey information about the sensor 
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surface (e.g. mass and density) and any molecular interaction that caused a change to the 
refractive index of the medium. 
                                            
Figure 1.3 SPR reflectivity curve and sensorgram  
 
1.4.2 Signal from Molecular Bindings and Interactions 
The binding of the biomolecules on the sensor surface results in the change of the 
refractive index, therefore it can be detected by SPR. This happens as photons have a 
different velocity in different media, and the energy of the plasmons is changed when the 
composition of the medium changes, consequently, change the angle of incident light at 
which the resonance occurs. Therefore, a shift in the reflectivity is a direct method of 
detection, which avoids the drawbacks of labelling method. SPR also enables the 
continuous observation of binding interaction between molecules by monitoring this 
change in SPR response over time; the curve is known as sensorgram (Figure 1.4a, edited 
from ref. 46). The sensitivity of SPR biosensors can be measured by developing a 
calibration curve, in which the SPR measurements are repeated at different concentrations 
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of analytes and the results of resonance angle shift per concentration is plotted (Figure 
1.4b). This analysis is used to identify the limit of detection (LOD) as well as the linear 
range of the sensing system. 
 
 
 
Figure 1.4 (a) The change in reflected light intensity is converted to SPR angle shift in a sensorgram 
showing a real-time monitoring of the binding process (b) Sensitivity or calibration curve obtained 
after measuring the response of different analyte concentrations 
 
 Theoretical basis of SPR  
The working principal of the SPR technique is based on utilizing visible light to 
excite free electrons on a surface of a metal. This causes surface plasmons to travel along 
the metal surface, creating an evanescent field to the adjacent medium in contact with the 
metal. The fundamentals of this techniques are based on the reflectivity and refractivity of 
lights travelling from and to materials having different refractive indexes. 
 
 
 12 
1.5.1 Total Internal Reflection and Evanescent Waves 
Refraction is the bending of a wave when it enters material where it will travel at a 
different speed (Figure 1.5). Consider an upper material having a refractive index, n2, that 
is greater than the refractive index of the lower material, n1. When an incident light travel 
from a material of greater refractive index into a material with lower refractive index, the 
light bends away from the normal line so that q2 > q1.  The angle q2 is called the angle of 
refraction. If the angle of incident, q1, further increases, more light is reflected and 
refracted. When the light reaches the right angle of incident, then the light travels right 
along the boundary so that q2 becomes 90o. The angle of incident when this condition 
occurs is called the critical angle, qc. When the angle of incident is bigger than the critical 
angle (q1 > qc), where sin (qc) = n2/n1, none of the light travels along the boundary but all 
of it is internally reflected. This phenomenon is known as the Total Internal Reflection 
(TIR), when the incident wave cannot pass through the boundary and is totally reflected to 
the incident medium.   
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Figure 1.5 a) Refracted and reflected light, b) Critical Angle and c) Total Internal Reflection (TIR) 
 
Evanescent waves are then formed in the lower refractive index medium n2 under 
the condition of TIR. The amplitude of this type of standing waves decays exponentially 
with the distance to the interface of the media 1 and 2. The magnitude of the parallel wave 
vector of the evanescent wave, kev, is given by: 
           
                 𝑘#$ = 	'	(	 𝑛*	𝑠𝑖𝑛𝜃														                         Equation 1.                                  
 
Where w and c are the angular frequency and the speed of light in vacuum, respectively. 
For practical purpose, Equation 1 can also be expressed in terms of wavelength, l: 
 
                    𝑘#$ = 	 ./	0 𝑛*	𝑠𝑖𝑛𝜃                                        Equation 1a.     
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For non-absorbing media, the dielectric constant equals the square of the refractive index, 
ε = n2, where ε is the dielectric constant (or permittivity) and n is the refractive index. 
Therefore, for plane polarized light under TIR condition, the wave vector projection of the 
photons on the metal surface can also be expressed as: 
 																								𝑘#$ = 	'	(	 1𝜀3	𝑠𝑖𝑛𝜃      or        𝑘#$ = 	 ./	0 1𝜀3	𝑠𝑖𝑛𝜃                  Equation 2. 
 
1.5.2 Surface Plasmons  
When a metal surface is coupled to a prism where the electron is excited, this 
configuration produces surface plasmon. Surface plasmon is defined as an electromagnetic 
wave propagating at the interface between a metal and a dieletric.44, 47 Maxwell’s theory of 
surface plasmons describes the free electrons of a metal as an electron liquid of high density 
(i.e. plasma) and density fluctuations on a surface of this liquid as surface plasmons. 
Plasmons can also be thought as the particle name of this electromagnetic wave that has 
mass and velocity. The surface plasmon wave vector function consists of complex 
dielectric permittivity of the dielectric that is the medium next to the metal, denoted by ε1 
and the complex dielectric permittivity of the metal, denoted by ε2. For photon-plasmon 
interaction, only the parallel vector component of surface plasmons matters. This is 
because plasmons are confined to the plane of the gold film.  
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The following equation defines the wave vector of a parallel surface plasmon wave, 
kSP: 
		𝑘45 = 	'	(	 6 	7879	78:79              or          𝑘45 = 	 ./	0	 ; 	<99<=9	<99:<=9          Equation 3.  
 
Where ng is the refractive index of the gold film.     
 
Surface plasmons are not present inherently on these interfaces. Instead they can be created 
via excitation by e.g. light. The most common approach to excitation of surface plasmons 
are the Kretschmann geometry 48 and Otto geometry (Figure 1.6).49  
 
 
Figure 1.6 Excitation of surface plasmons in the a) Kretschmann and b) Otto configuration 
 
In the Kretcshmann configuration, the metal film is placed directly onto the glass prism. 
The light illuminates the glass block, and an evanescent wave penetrates through the metal 
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film. The plasmon is excited at the outer side of the film. This configuration is used in most 
practical applications. 
1.5.3 Excitation of Surface Plasmon Resonance  
For surface plasmon resonance to occur, a coupling method between the surface 
plasmons and photons is required. In Kretschmann configuration, the prism itself acts as a 
coupler (Figure 1.7). The metal surface is positioned next to the prism and surface 
plasmons are generated at the metal-dielectric interface.50 Wave vector coupling (i.e. 
surface plasmon resonance) takes place when photon wave vector projection on the metal 
kev equals the parallel vector component kSP of surface plasmon: 
 
                                       𝑘#$ = 	𝑘45             
         
																																													'	(	 1𝜀3	𝑠𝑖𝑛𝜃	 = 			 '	(	 6 	7879	78:79	  or 
 
        																																					./	0 𝑛*𝑠𝑖𝑛𝜃	 = 			 '	(	 ./	0	 ; 	<99<=9	<99:<=9	                             Equation 4. 
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Thus, using Equation 4, the angle required for the resonance, θSPR, is related to n2 when n1 
and ng are fixed, giving the equation: 
 
																																																					𝜃45> = 	 𝑠𝑖𝑛?* @ *<8 	;	<99<=9	<99:<=9A                      Equation 5. 
         
 
Figure 1.7 Schematic of the Kretschmann configuration of the SPR used in this study. When the 
projected wave vector of the incident light does not match the vector of surface plasmons no 
excitation occurs (a). At a certain incident light angle the projected wave vector of the incident light 
matches the wave vector of surface plasmons (b). 
 
The excitation is possible when using p-polarized light (i.e. polarization occurs 
parallel to the plane of incidence), while s-polarized light (i.e. polarization occurs 
perpendicular to the plane of incidence) cannot excite electronic surface plasmons.51 
Typical metals that support surface plasmons are silver52 and gold, but other metals such 
as aluminum and copper,53 have been used. Gold is mostly selected, because of its chemical 
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inertness, high wavelength surface plasmons and the methods to functionalize the surface 
with various biomolecules using self-assembled chemistry have been established.  
 
 
 Challenges in SPR biosensors  
The works presented in this thesis are focused on improving current sensors and 
designing new sensing interface for the application of SPR in biomedical research. In the 
following sections, the challenges and proposed solutions that break the limitations of SPR 
biosensors are described.  
1.6.1 Non-specific Binding (NSB) 
Non-specific absorption or binding of unwanted analyte either on the sensing 
surface or on the capture ligand has always been a challenge in optimizing the design of 
surface-based and label-free biosensors (Figure 1.8). When this occurs, an optimum 
sensitivity and selectivity cannot be achieved, because it causes an elevated background 
signal that cannot be discriminated from the specific binding.54 Ideally, the biomolecules 
of interest must bind with high affinity and selectively to the sensitive area.55 Non-specific 
binding occurs from many reasons, mainly the combination of biomolecules-substrate 
interaction, substrate stickiness, non-specific electrostatic and hydrophobic binding to 
charged surface, and adsorption of molecules in free spaces.56 This is especially important 
in clinical applications, where actual bodily fluids are used as test samples, and it contains 
many proteins that prone to adsorb nonspecifically to the sensing surface. There are many 
strategies to reduce or eliminate this type of NSB, grouped into two categories; physical 
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and chemical blocking methods. The most popular and simplest method to prevent NSB is 
to use blocker proteins that adsorb to surfaces so that only the analyte binds only to the 
capture ligand (Figure 1.8b). The examples of the blocker proteins are serum albumins 
(BSA), 57 and casein.58 Although BSA is easily accessible, it is not the preferred method to 
prevent NSB, as addition of BSA often causes a nonuniform layer and some proteins can 
still adsorbed on to a BSA layer.59  Chemical method such as the self-assembled 
monolayers  (SAMs) offers better resistance to NSB, in which the alkanethiol SAMs 
(Figure 1.9a) are one of the most popularly used bioreceptor linker molecules, due to two 
major advantages: plentiful functional groups to immobilize bioreceptors and a dense 
monolayer that allows little NSB.60, 61 In our studies, SAMs prepared from thiolated poly-
(ethylene glycol) (PEG) and 11-mercaptoundecanoic acid (MUA) (Figure 1.9b) were 
mostly used, as the terminal hydroxyl groups provide functionalities needed for amine 
containing biomolecules with the standard EDC/NHS coupling method.62   
In addition to the traditional SAMs, we developed an SPR surface using DNA self-
assembled monolayers (DNA-SAMs) for a direct immobilization of DNA on the gold 
surface.63, 64  In this method, the surface is also backfilled with a short chain alkanethiolates, 
such as mercaptohexanol (Figure 1.10, edited from ref. 65). The reason for this dense 
molecular packing is to avoid the interaction of the nitrogen-containing base pairs of DNA 
with the substrate, causing the DNA chain to collapse.65 Furthermore, the filling of 
mercaptohexanol in the gap assists in the formation of the SAMs by erecting the DNA 
strands on the surface. This also prevents NSB to occur, as well as promoting a controlled 
orientation for the interaction of the DNA with subsequent biomolecules. 
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Figure 1.8 Schematic representation of the non-specific binding and random/uncontrolled 
orientation of capture ligand. (a) Some ligand molecules are unavailable for analyte binding as a 
result of random orientation and non-specific binding occurs between the analytes and the surface, 
(b) Specific binding of analytes to the controlled orientation ligand while the surface is covered 
with a blocking agent 
 
 
Figure 1.9 Schematic representation of SAM surfaces on gold, modified with (a) alkanethiol 
(showing hexadecanethiol, HDT) and (b) MUA 
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Figure 1.10 Schematic representation of DNA-SAMs on gold substrate followed by incubation 
with mercaptohexanol to assist the formation of the self-assembled monolayer  
 
1.6.2 Uncontrolled Orientation 
The efficiency of biosensing surface depends highly on the efficiency of the binding 
between the capture ligands and the analytes. Although the surface can be entirely covered 
with capture ligands, it is known that not all of them will bind to the analytes due to steric 
hindrance. One reason is the random orientation or nonsite-specific immobilization of the 
ligands on the surface, resulted from a passive non-covalent adsorption (Figure 1.11b).66 
This is particularly a concern for antibodies, which are used in immunoassays, as randomly 
adsorbed antibodies have poor affinity towards their antigen.67 Naturally, this uncontrolled 
orientation reduces the performance of a biosensor. Therefore, to achieve maximum 
binding, the capture ligands must be oriented in a way that their binding active sites are 
entirely exposed to the solution and accessible (Figure 1.11a). A controlled ligand 
orientation can be achieved by an affinity-based binding between a target analyte and its 
surface immobilized partner. Most used examples are the Fc region of immunoglobulin G 
(IgG) to protein A and protein G, biotin to avidin, histidine to metal chelates such as Ni-
 22 
nitriloacetic acid (NTA), and carbohydrate residues to lectin.64, 68 Our interest has been in 
the IgG-protein A system, in which the position of the antibody binding site (Fab region) 
remains accessible for binding with the antigen where the Fc region of the antibody binds 
specifically to protein A due to a strong affinity.69 As shown in Figure 1.11a, the presence 
of protein A produces a uniform assembly and controlled orientation of IgG leads to an 
effective binding with the antigens, compared to the random orientation. We demonstrated 
the use of thiolated protein A in Chapter 3, combined with a supported lipid bilayer 
membranes (SLBs) for a successful immunosensing on an antifouling surface. Other than 
the antibody-protein A system, we also employed other site-selective methods like biotin-
strepavidin and antibody-antigen as linkers that bind the analytes to the biorecognition 
elements.70 
 
Figure 1.11 Schematic representation of (a) Controlled orientation of IgG binds to Fc binding 
domain of protein A and (b) Random orientation in absence of protein A 
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1.6.3 Surface Fouling from Complex Media 
The use of SPR biosensors in medical diagnostic would require the analysis of 
actual clinical samples, mainly of blood plasma or serum. Blood plasma is the yellowish 
colored liquid that make up 55% of the whole blood, while serum consists of plasma 
without fibrinogen.71 Both contains various proteins, antibodies, antigens, and hormones; 
all have the potential to adsorb on the biosensor surfaces nonspecifically. This effect, also 
known as “fouling”, causes a disturbance to the SPR signal from the intended target 
analyte, as the nonspecific contents accumulate on the surface, which then alter the 
refractive index measured by SPR. Much research has been done in developing antifouling 
surfaces, while still maintaining the excellent binding recognitions. Other than the PEG 
based SAMs, the zwitterionic surfaces and polymer brushes also exhibit antifouling 
property, due to their net neutral surface charge and closely-packed polymer chains, 
respectively.72 We studied different types of phospholipids, specifically 
phosphatidylcholine (EPC and POPC) and phosphatidylglycerol (POPG)  as antifouling 
surfaces when formed as a supported lipid bilayer membrane on a protein A surface.  
The phospholipid is the type of lipids that construct cell membrane, forming lipid 
bilayers because of their amphiphilic property.73 A solid supported lipid bilayer membrane 
(SLB) is usually constructed from lipid vesicle fusion followed by adsorption on a 
hydrophilic surface, which then rupture to form a continuous surface of supported 
membrane as shown in Figure 1.12.74 Other advantages of SLB includes easy incorporation 
of proteins, small molecules, nanoparticles and other species on the membrane surface or 
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inserted into the membrane, which can be used to study biomolecules interaction on cell 
membrane surfaces.75  
 
 
Figure 1.12 Possible mechanisms of supported bilayer formation. Vesicles adsorb, deform, and 
rupture to form an SLB. Under some conditions, vesicle-vesicle fusion occurs as an intermediate 
preceding vesicle rupture. Reprinted from Ref. 54, Copyright 2006, with permission from Elsevier 
 
 
1.6.4 Weak Signal and Low Sensitivity  
The growing interest of biosensors for biomedical applications is mostly focused on 
detecting ultra-low concentrations of target analyte like disease biomarkers,76, 77 and low 
molecular weight molecules such as DNA, RNA and small molecules.31 This is particularly 
important when diagnosing infectious diseases at an early stage. Therefore, one of the 
major challenges is to develop biosensors with sufficient sensitivity and low detection limit 
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by amplifying the signal through different strategies. In SPR biosensors, signal 
amplifications were achieved by enhancing the small changes in refractive index so that a 
large resonance angle output is obtained. Established methods such as sandwich assays 
(Figure 1.13a)  (for examples antibody-antibody,78 avidin-antibody-strepavidin,79 aptamer-
antibody80) and gold nanoparticles81 (AuNPs) (Figure 13b) (figures edited from ref. 84 and 
85) have been used to improve SPR detection. The main advantage of AuNPs is the 
versatility for conjugation with many biomolecules including DNA, proteins, antibodies 
and cells.82 Nanoparticles, in general, increase SPR sensitivity based on the pseudo mass 
increase.36 In more recent developments, nucleic acid amplification methods such as rolling 
circle amplification (RCA) and loop-mediated isothermal amplification (LAMP),  have 
been widely utilized for biosensing including for infectious diseases or cancers.83 However, 
the limitation of using nucleic acid methods is it requires high temperature operation (30 – 
65 oC) because of the enzymes involve in the mechanisms. In our studies, we employed 
signal amplification via AuNPs and a room temperature DNA self-assembly, which are 
demonstrated for detection of Malaria and for immunosensing purposes. 
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Figure 1.13 Schematic representation of (a) sandwich assay and (b) AuNPs enhancement 
strategies.  
 
1.6.5 Cell-based SPR 
Although the advantages of SPR, especially the real time and label-free features, 
are very much attractive for the studies of living cells, the progress of using SPR in this 
field is not as rapid as other biomolecules.  Main reason is the nature of SPR technique 
itself, as the sensitive evanescent field in the SPR setup is limited to around 300 nm depth 
from the surface, and thus is not sufficient to detect interactions of the whole cells. 
However, there are a lot of unknown features on the interactions at the cell-substrate 
interface that remain to be explored. Our interest is to develop an SPR method for 
monitoring the signal based on the cell’s uniformity, morphology and detachment process 
from the surface. This is particularly useful for cancer cells toxicity and therapeutic studies, 
as the process of  apoptosis changes the morphology of the cells. Therefore for adhered 
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cells any changes happened at the cell membrane within 300 nm from the substrate can be 
monitored by SPR. 
 Objectives and Scope of Dissertation  
The goals of this dissertation are to demonstrate the great potential of SPR 
biosensors in medical applications, mainly for diagnosis of infectious diseases and cancers. 
This was achieved through advanced SPR surface chemistry, biomolecular binding 
interaction, signal amplification, antifouling surfaces, novel interface and combination of 
at least two of these strategies. The challenges in biosensing development were scrutinized 
in order to find the gaps in realizing SPR biosensors to a level more superior than current 
bioanalytical methods.  The overarching goals of the proposed work is to enable integration 
of SPR into a portable field-used biosensing system complete with sample preparation, 
detection platform, data processing and user interface.  
Chapter 2 of this thesis is on the development of a dual signal amplification method, 
which comprised of AuNPs and DNA hybridization chain reaction (HCR) to improve the 
sensitivity of DNA biosensor for the detection of malaria parasite. The motivation for this 
work was primarily the urgent need for early detection of malaria and portable biosensors 
that can be brought into hardly accessible malarial regions. The highlights of this work are 
the simple DNA detection scheme with room temperature operating condition, and the use 
of complex media to mimic the actual clinical test does not compromise the sensing 
performance. 
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In Chapter 3, we demonstrated an SPR immunosensor with antifouling surface and 
controlled capture antibody orientation, using lipid bilayers interface and affinity-based 
recognition via protein A, respectively. The latter enables the antibodies active site to be 
fully accessible to antigen binding. The mobility of different types of lipid after bilayer 
membrane was characterized using Fluorescence Recovery After Photobleaching (FRAP) 
and the results were related to the membranes’ antifouling property. As the proof-of-
concept, IgG and Cholera toxin (CT) were used as the detection model systems. 
Chapter 4 describes how SPR can be used to monitor HeLa cells morphological 
changes and detachment from substrate surfaces, when the cells on the SPR chips undergo 
apoptotic phase after being treated with a cell death inducer, in this work, hydrogen 
peroxide (H2O2). The SPR signals were comparable to cell confluency, which is a direct 
cellular parameter for apoptotic cells. An interesting finding during the period of this work 
is the mathematical model analysis that relates SPR signal to the thickness of cells layer 
and refractive indexes in the vicinity of sensing surface. Although cell-based SPR offers 
huge potential in cancer diagnosis and cells toxicology studies, it remains underrated and 
is less explored than other SPR biosensors.  
We conclude the work done and provide some insights towards the future of SPR 
biosensors for medical applications in Chapter 5.  
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 SPR Biosensor for the Detection of Malaria 
Plasmodium falciparum DNA with Signal Amplifications  
 
ABSTRACT 
Malaria remains a deadly disease to this date despite recent advances in its 
diagnosis, treatment and management. For the diagnosis, PCR detects a specific DNA 
sequence and is highly sensitive but has disadvantages such as high cost, need of specialist, 
and poor field deployability. We report here a DNA-based surface plasmon resonance 
biosensing of Plasmodium falciparum, the most fatal parasite associated with malaria.  
Direct detection of the parasite DNA by an immobilized capture probe complementary to 
the target DNA was achieved with unremarkable performance. To improve the sensitivity 
and limit of detection, we introduced signal amplification strategies using the concept of 
DNA self-assemblies via hybridization chain reaction (HCR), which triggers formation of 
DNA nanostructures, and a further signal amplification by gold nanoparticles (AuNPs). 
We achieved a linear sensitivity range from 0.1 nM to 0.1 µM of target DNA, with higher 
signal and lower detection limit were obtained after the AuNPs enhancement step. The 
sensitivity was not compromised when the detection was conducted in human blood 
plasma, which was used to mimic actual diagnostic sample. Overall this method 
demonstrates great potential of SPR in clinical application, and successively to foster an 
effective treatment and control of Malaria. 
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 Introduction 
Malaria is a dangerous disease caused by blood-borne parasites of the genus 
Plasmodium that live and reproduce in two types of hosts; female Anopheles mosquitoes 
and humans. In this cyclical infection, the parasites are transmitted into the human 
bloodstream, then travel to the liver to mature before multiplying in the red blood cells and 
continue the cycle by infecting more cells.1 Most human infections are caused by 
Plasmodium falciparum, which also causes severe organ damage, respiratory distress, 
coma, and anemia, often leading to fatality.2, 3 In the recent World Health Organization 
(WHO) Malaria Report, 219 million cases and 435 000 related deaths have occurred in 
2017 based on data from 87 countries and areas with ongoing malaria transmission.  
Although malaria parasites achieve maturity in 48 hours, an early diagnosis remains 
a challenge, as the density of this parasite is very low at this stage and therefore not 
detectable by the traditional malaria diagnostic methods, namely blood film microscopy or 
the immunoassay rapid diagnostic tests (RDTs).4 Molecular diagnostic methods based on 
malarial DNA amplification such as polymerase chain reaction (PCR) and nucleic acid 
sequence-based amplification (NASBA)5, 6 have proven to be more sensitive and specific 
(thus, allowing multiplex detection) than the RDTs.7 However, the nucleic acid detection 
methods require well-equipped laboratories and trained technicians, which are inaccessible 
in the poor endemic regions.8 
Evidently, there is a need for a more advance method beyond the current diagnosis 
and clinical detection of malaria. Biosensors have been developed to provide highly 
sensitive, rapid, specific, simple and field deployable detection of biomolecules in various 
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applications.9, 10 In the case of malaria, recent development of biosensors have focused on 
targeting parasite-related biomarkers such as Plasmodium falciparum histidine rich protein 
II (PfHRP-II), Plasmodium falciparum lactate dehydrogenase (PfLDH), heme, and 
hemozoin.11, 12 Biosensors for the direct detection of the malaria parasite’s DNA 
unfortunately are still lacking and are very much needed for diagnosis in the early stages 
of infection. Previously, a quartz crystal microbalance (QCM) biosensor was developed 
for the detection of post-PCR amplified DNA of P. falciparum and P. vivax that was 
extracted from patient blood samples.13, 14  
In our study, we further improve the sensitivity and practicality of the malaria DNA 
biosensor by employing surface plasmon resonance (SPR), a surface-sensitive, label-free 
optical transduction biosensor.15, 16 Compared to labeled optical biosensors such as 
fluorescence and colorimetry, SPR offers several advantages that includes real-time 
measurement, simplified design, universal detection, field-deployability and great potential 
in clinical applications.17-20 Numerous studies on SPR biosensors have been reported on 
the detection of proteins,21, 22 antibodies,23 microRNA,24, 25 DNA,26 and cancer 
biomarkers.27, 28  
To achieve the goals, we developed an SPR biosensor for a highly sensitive direct 
detection of P. falciparum DNA based on a concept of DNA self-assembly, via 
hybridization chain reaction (HCR),29-31 with  signal amplification using gold nanoparticles 
(AuNPs).26 The self-assembly assay of HCR, which usually consists of two single stranded 
DNAs complementary to each other can hybridize and form long DNA nanostructures and 
has been utilized as amplification technique for sensitive detection of nucleic acid 
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implemented in room temperature.32 A further SPR signal amplification using 
nanoparticles is often integrated with DNA self-assembly approach, for example AuNPs,33, 
34 aggregation of network of AuNPs,35 DNA modified AuNPs,36 and magnetic 
nanoparticles.37 AuNPs was chosen because it is proven to be effective in SPR signal 
enhancement due to high refractive index and the electronic coupling interaction between 
the localized SPR (LSPR) of AuNPs and the resonance wave of the gold film on the sensor 
chip.38 
Our biosensor was also tested in human blood plasma to mimic clinical samples, 
and the non-specific binding on the sensor surface was systematically assessed to ensure 
the sensing performance is not compromised by the complex media and AuNPs. The 
graphical representations in Figure 2.1, shows how our biosensor fill the gaps in malaria 
diagnosis. The potential benefits of this study are numerous; the amplification methods can 
be applied to other DNA-based biosensors in drug discovery, biomedicine, food safety and 
environmental monitoring,39 and combining with SPR features this biosensing strategy is 
an exciting opportunity to realize compact and portable biosensors for field use. 
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Figure 2.1 Schematic representation of malaria diagnostics including biosensors for the DNA level 
detection. The boxed figure illustrates the principle of SPR for direct detection of target DNA by 
the immobilized capture probe 
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 Experiment Section 
2.2.1 Materials 
Sulfuric acid (H2SO4), Hydrogen peroxide (H2O2), Hydrochloric acid (HCl), Nitric 
acid (HNO3), Sodium phosphate dibasic (Na2HPO4), Potassium phosphate monobasic 
(KH2PO4), Sodium Chloride (NaCl) and Potassium Chloride (KCl) were from Fisher 
Chemical. Sodium citrate tribasic dehydrate, Trizma Base Gold (III) chloride trihydrate 
(HAuCl4), 6-mercapto-1-hexanol (MCH), and Tween 20 was from Sigma. Thiolated poly-
thymine (T20-SH) and Biotinylated poly-thymine (Biotin-T20-SH) reconstituted to 100 µM 
in H2O, and the probe sequences are listed in Table 2.1 were from IDT. The probes were 
stored in IDTE buffer (10 mM Tris, 0.1 mM EDTA, pH 8.0) (100 µM) at 4oC, and dissolved 
in Tris buffer (pH 7.4) prior to use in SPR. Strepavidin was from Thermo Scientific and 
reconstituted in PBS 1x. Citrated human blood plasma (Catalog no. P9523) contains 4% 
trisodium citrate as anticoagulant was purchased from Sigma. The hybridization buffer (pH 
7.5) contained 40 mM Tris, 250 mM NaCl, 40 mM KCl and PBS 1x 10 mM (pH 7.4) were 
used. The pH of buffer solutions was adjusted with HCl. All buffers were filtered and 
degassed before storage and use. Nanopure water (> 18 MΩ.com), purified through a 
Barnstead E-Pure filtration system (Thermo Scientific, Rockford, IL) was used for all 
reagent preparations.  
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Table 2.1 DNA sequences employed in this work 
 
*The italic and underlined parts are complementary sequences, respectively 
2.2.2 Apparatus 
Gold chips were fabricated using an E-beam evaporator Temescal BJD 1800 in the 
UCR Center for Nanoscale Science and Engineering (CNSE) facility. All absorbance 
spectra were obtained using a Cary 50 UV-Vis spectrophotometer (Agilent Technologies, 
Santa Clara, CA). SPR spectroscopy measurements were carried out in room temperature 
using a commercial instrument from NanoSPR (Addison, IL) consisting of a dual channel 
fluidic setup (30 µL), a glass prism, and a 650 nm light source. Centrifugation was carried 
out using Eppendorf Centrifuge 5415C. 
2.2.3 Gel electrophoresis 
All oligonucleotides were dissolved in Tris-ethylene diamine tetraacetic acid buffer 
(pH 8.0, 10 mM Tris-HCl, 1mM EDTA) prior to use or stored at −20 °C. The hybridization 
buffer (pH 7.5) contained 40 mM Tris, 250 mM NaCl, 40 mM KCL. The self-assembly of 
HCR amplification reaction was ascertained by 8% native polyacrylamide gel 
electrophoresis in 1 × TBE (90 mM Tris-HCl, 90 mM boric acid, 2 mM EDTA, pH 7.9) 
buffer at constant voltage of 100 V for 40 min. The gel electrophoresis was carried out on 
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a DYY-6C electrophoresis analyzer (Liuyi Instrument Company, China) and imaged on a 
Bio-Rad ChemDocXRS (Bio-Rad Laboratories, USA). 
2.2.4 Gold Nanoparticles Synthesis and Conjugation. 
Gold nanoparticles were prepared using a standard citrate reduction method.40 
Briefly, to synthesize 13 nm gold nanoparticles, HAuCl4 was dissolved in 500 mL of 
distilled water in glassware previously cleaned with Aqua Regia (3:1 HCl to HNO3), giving 
a final concentration of 1 M HAuCl4. This solution was heating until boiling with vigorous 
stirring, then a 50 mL of 38.8 mM solution of sodium citrate tribasic dihydrate was added, 
and the solution was boiled for another 15 min before being allowed to cool to room 
temperature. These nanoparticles were functionalized with thiolated oligonucleotides 
consisting of biotinylated poly-thymine, and poly-thymine in a 1:1 ratio according to a 
protocol previously reported in our group.41 The synthesized gold nanoparticles were used 
as-is before the addition of 5 nmol DNA-Biotin (100 µM, H2O) to 2 mL of concentrated 
gold nanoparticles. Immediately, 40 µL of citrate-HCL (500 mM, pH 3.0) was added 
before the addition of 20 µL of 10% (v/v) Tween 20.  Finally, 250 µL of 5M NaCl was 
added to the mixture and the nanoparticles solution was stored overnight at 4 °C. Each 
addition step was followed by vortex and sonication. Excess reagents were removed from 
the nanoparticle solution by centrifugal filtration (Amicon, MWCO 50 kDa), washed five 
times with PBS, and the resulting Au-DNA-Biotin conjugates was stored at 4°C after 
addition of 250 µL buffer. UV-Vis was performed to determine the concentration of gold 
nanoparticles and to assess the conjugation result. 
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2.2.5 Gold chip preparation 
The SPR chips were fabricated by depositing a 2 nm thick chromium layer (0.5 
Å/s), followed by a 50 nm thick gold layer (1 Å/s), at 5x10-6 Torr via an e-beam evaporator. 
For the cleaning of the glass slides, 80 mL of piranha solution consisting of 3:1 v/v H2SO4 
and 30% H2O2 was prepared in a 100 mL beaker. In a separate round glass container, BK-
7 glass microscope slides (refractive index = 1.5167) ware arranged after which the piranha 
solution was poured into and boiled for 30 min or until all bubbles disappear.  The container 
was removed from the hot plate and cooled to room temperature. After that, the slides were 
thoroughly rinsed with DI water and blow dried under compressed air.  
2.2.6 Sensing chip preparation 
Prior to immobilization of the thiolated capture probes onto the gold chips via the 
Au-S bond, the chips were rinsed thoroughly with ethanol and then air dried. In the first 
step, 500 µL of 1 µM thiolated capture probe diluted in immobilization solution (Tris 
buffer, pH 7.5) was pipetted onto the gold chip then incubated for 2 hours. Next, 500 µL 
of 1mM 6-mercapto-1-hexanol (MCH) was incubated on the gold chip for 1 hour. MCH, a 
short-chain thiol with hydrophilic hydroxy group, is co-assembled with probe DNA for 
reducing the non-specific binding of DNA and making the DNA chain erect on the gold 
surface.42 The chips were rinsed with DIW and dried with N2 after each step. 
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2.2.7 SPR of DNA detection and amplification 
Prior to the experiments, a thin layer of matching fluid (Immersion Fluid from 
Cargille Laboratories) was applied to the sensing chips. All biological components were 
diluted prior to injection with hybridization buffer, to achieve the final concentrations. The 
hybridization buffer was also used as the running buffer at a flow rate of 5.0 mL / h. After 
30 mins of steady baseline as monitored using SPR, the detection of target DNA and the 
amplification steps was carried out by injecting the probes and other binding molecules 
into the channels, in sequence, accordingly. All steps were separated by a buffer wash of 
at least 15 minutes. The measurements were repeated for at least three times, where the 
angle shift (Δθ) was calculated after subtracting the non-specific binding in control 
channels from specific binding in the experiment channels after rinsing. 
 
 Results and Discussions 
2.3.1 Characterization of the proposed assay  
The feasibility of the HCR system was verified using polyacrylamide gel 
electrophoresis (PAGE). The results confirm the formation of DNA assemblies from the 
hybridization assay. As shown in Figure 2.2, the mixture of capture, target and H1 DNA 
hybridized with each other (lane 6) while in the presence of H2 longer DNA fragments are 
formed (lane 7 and 8). 
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Figure 2.2 8% native polyacrylamide gel electrophoresis analysis of hybridization chain reaction 
corresponding to hybridization of different chains. Lane 1-4 represent Capture, Target, H1 and H2, 
respectively. Lane 5: Capture and Target; Lane 6: Capture, Target and H1; Lane 7, 8: hybridization 
chain reaction with 1 μM and 2 μM H1, H2, respectively. 
 
 
2.3.2       UV-Vis Analysis of Conjugated Gold Nanoparticles.  
The presence of protein conjugated to the AuNPs were analyzed using UV-Vis 
spectroscopy (Figure 2.3) and the size of gold nanoparticles was determined from the 
data43. We used AuNPs of 13 nm in diameter because smaller nanoparticle are more stable 
in solution,  easier to prepare, and have well-established bioconjugation protocols 
compared to larger nanoparticles (> 15 nm).44 In addition, a smaller diameter allows for 
more biotinylated AuNP binding to streptavidin and has less non-specific binding, resulting 
in a larger SPR signal. The unconjugated 13 nm AuNPs exhibit maximum UV absorbance 
at a wavelength of 520 nm, which is consistent with values typically reported for this size; 
and we calculated the concentration of our AuNPs to be 3 nM. For conjugation to DNA 
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the gold nanoparticle solution was used at the synthesized concentration. After conjugation, 
the increased particle size caused a red-shift to 525 nm in the maximum absorbance peak,38, 
45 and the concentration for Au-DNA-Biotin (1:1) was calculated to be 10 nM. A second 
maximum peak at 260 nm confirms the presence of protein. All dilutions prior to SPR 
measurements were achieved by addition of Tris buffer. 
 
Figure 2.3 Absorbance spectra of 13 nm AuNPs before and after DNA-Biotin conjugation 
 
2.3.3 Analysis of target DNA hybridization on sensing surface 
With the confirmation of capture, and the target DNA probes hybridizing as 
intended, it is imperative that the hybridization translates to a binding signal on SPR as 
well. For this purpose, we constructed a biosensor for the detection of target DNA when it 
hybridizes with the capture probe. The chip is docked into SPR equipment followed by 30 
min baseline, after which 0.1 µM of target DNA was injected only in the experiment 
channel (Figure 2.4). After 90 minutes of incubation time, the flow pump was turned on 
for the rinsing step. A shift in resonance angle was observed resulted from the specific 
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binding of the probes, while the signal remains in the control channel. Although the binding 
is validated, a small angle shift (Δθ = 0.02o) was observed, consistent with a mass of the 
hybridized structure of less than 50 bp as seen in Lane 5 of Figure 2.2. This small angle 
shift justified a need for signal amplification to improve sensitivity and to detect at even 
lower concentration. 
 
Figure 2.4 SPR sensorgrams representing detection of target 0.1 µM DNA 
 
 
2.3.4 Feasibility of biosensing strategy with HCR amplification 
In this amplification strategy, HCR probes (H1 and H2) were introduced after 
incubation of target DNA. One terminal of target DNA binds to the capture probe and the 
other terminal triggers HCR through hybridization with H1. The remaining sequence of H1 
is complementary to H2, subsequently triggering linear amplification and building up DNA 
nanostructures. We again used SPR to determine the binding signal of this scheme. In the 
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experiment channel, a pre-mixed 0.1 µM target DNA, 1 µM H1 and 1 µM H2 was injected 
into the flow channel and incubated for 90 min. In the control channel, only H1 and H2 
was injected. After rinsing, an increase of angle shift (Δθ = 0.03°) was observed with HCR 
molecules while we observed no change in the absence of target DNA (Figure 2.5A). 
2.3.5 Optimization of HCR Condition 
In order to evaluate optimum conditions for this assay, several experiments were 
conducted with the aim to improve the hybridization process as to achieve higher SPR 
signal. From literatures, the formation of HCR molecules is one of the important factors in 
getting the most benefit from this amplification strategy. For example, different DNA base 
pairs  that are most efficient to produce highest SPR signal was studied,46 and it is known 
that surface plasmon wave is sensitive within 300 nm from the metal surface.47 The 
efficiency of the self-assembled DNA can also be affected by steric hindrance when the 
nanostructures are too close to each other.48 Other factors to be considered include 
hybridization reaction time and the volume ratio between HCR probes.31, 46 In this work, 
the hybridization reaction was evaluated by comparing one-step reaction to two-step 
reaction, where two-step reaction would trigger the formation of larger HCR product. In 
two-step reaction, target DNA is injected first and let incubated and rinsed, before H1 and 
H2 probes are injected for the self-assembly to happen. While target DNA, H1 and H2 are 
premixed and injected at the same time in one-step reaction. The result of two-step reaction 
of 0.1 µM target DNA is shown in Figure 2.5B. By comparing to the one-step reaction, a 
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higher angle shift was observed for the two-step reaction (Δθ = 0.04°), consistent with the 
above discussion. Therefore, the two-step reaction was chosen for the rest of this study.  
 
 
 
Figure 2.5 Sensorgrams from a typical SPR experiment of 0.1 µM target DNA with HCR 
molecules H1 and H2 for linear DNA amplification strategy using one-step (A) and two-step (B) 
method. Red line indicates control channel without target DNA 
 
 
2.3.6 HCR amplification capability 
To further explore if the proposed HCR assay can produce higher signal through 
better DNA hybridization efficiency, other factors such as hybridization process 
temperature and concentration of HCR probes were studied. Although experiments 
involving DNA-based HCR were mostly done at room temperature49, 50  it is worth 
investigating the effect of temperature on hybridization efficiency, as optimal hybridization 
of DNA occur at temperature higher than room temperature, which is between 37 to 42oC. 
All the oligonucleotides used in this experiment have melting temperature around 42-63oC, 
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which allows to study the hybridization behavior at temperature higher than room 
temperature.51 Some works reported heat treatment of probes mixture at 95oC for 5 min 
and cooled to room temperature slowly, after which partly hybridized probes were 
obtained.31, 52 Based on this information, the following experiments were conducted, and 
their results are shown in Figure 2.6, by pretreating mixture of H1 and H2, offline, at (A) 
45oC for 4 hours and (B) 95oC for 10 min, respectively, prior to injection into SPR. In the 
control channel, non-treated H1 and H2 was injected for comparison. A 1 µM target DNA 
was used while other steps we done following the same procedure for two-step reaction. 
From these results, it can be concluded that heat treatment of H1 and H2 probes has no 
effect, as the resonance angle shift between the two channels are similar after the HCR 
step.  
 
 
Figure 2.6 Effect of heat treatment on HCR molecules formation 
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To validate the HCR amplification, further experiments were conducted to compare 
the result from gel electrophoresis to SPR signal. As shown in Figure 2.7, the sensorgram 
of two SPR channels containing the same mixture of target and HCR probes as in Lane 6 
and 7 of gel electrophoresis were obtained with 1 µM target DNA. In the presence of target 
DNA with H1 and H2, making a complete HCR system, a high SPR signal (Δθ = 0.18°)  
was obtained because the self-assembled hybridization molecules have high molecular 
weights thus the signal was enhanced comparably and also because the target DNA could 
bind to many AuNPs due to the HCR molecules. Inversely, with the absence of H2, the 
increase of signal was almost negligible after HCR step. To evaluate the effect of the H1 
and H2 concentrations, one channel was injected with 1 µM of H1 and H2 and another 
channel with 2 µM of H1 and H2, while target DNA was fixed to 1 µM for both channels. 
These parameters are comparable to Lane 7 and 8 in the gel electrophoresis, and the 
sensorgram is shown in Figure 2.8. No significant difference was observed between the 
two channels after HCR step, thus a higher concentration of H1 and H2 has no effect on 
signal amplification. Possible explanation to this is that the volume ratio of H1 and H2 is 
1:1 and that 1 µM is the optimum concentration, as the same findings were reported by 
other studies.30, 34 Therefore 1 µM of H1 and H2 was chosen for the amplification study. 
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Figure 2.7 Sensorgram represent Red Line-Lane 6: Capture, Target and H1; Black Line-Lane 7: 
hybridization chain reaction with 1 μM H1, H2. 
 
 
Figure 2.8 Sensorgram represent Red Line-Lane 7, Black Line-Lane 8: hybridization chain 
reaction with 1 μM and 2 μM H1, H2, respectively. 
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2.3.7 Further amplification using gold nanoparticles (AuNPs) 
While HCR is proven to amplify the detection, a more sensitive strategy is required 
to improve the sensitivity and limit of detection (LOD) of this biosensor. We chose to 
incorporate AuNPs because it is proven to be effective in SPR signal enhancement due to 
high refractive index and the electronic coupling interaction between the localized SPR of 
AuNPs and the resonance wave of the gold film on the sensor chip.38 In this work, an SPR 
sensing strategy consists of thiolated capture DNA, target DNA, HCR probes H1 and H2 
with biotin end terminal, streptavidin and biotin-labelled gold nanoparticles was employed 
(Figure 2.9). Additional amplification was achieved when the biotinylated AuNPs binds to 
H1 and H2 assemblies via a streptavidin bridge. The result was plotted in a sensorgram 
(Figure 2.10) showing real-time binding of the biomolecules.  In step 1, 0.1 µM target 
DNA, was injected into experiment channel and incubated for 90 min. After rinsing, 1 µM 
H1 and 1 µM H2 were injected in both experiment and control channels. Next, 100 µg/mL 
streptavidin was injected, incubated and rinsed followed by 1.0 nM of 13 nm biotinylated-
AuNPs. After final rinse, a high SPR signal was observed in experiment channel (Δθ = 
0.40°) while in control channel a non-specific binding was observed (Δθ = 0.04°) but 
sufficient to say no significant increase in resonance angle was seen in the absence of target 
DNA. The higher SPR response in experiment channel after step 2 is gained by the DNA 
nanostructures, while no response in control channel as HCR molecules were not formed. 
In step 3, no SPR signal is obtained in control channel due to absence on biotin, while the 
signal increase in experiment channel as streptavidin binds to biotin on the terminal end of 
H1 and H2. Evidently, a much higher response was observed from AuNPs enhancement in 
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step 4 compare to step 2 and 3 for experiment channel. To find out if the sensing scheme 
is highly sensitive, we conducted SPR with lower concentration of target DNA. From the 
sensorgram in Figure 2.11, a smaller angle shift was obtained (Δθ = 0.28°) when the target 
DNA was reduced to 1.0 nM. In the following discussions, we compare the sensitivities 
when amplified by HCR and AuNPs. 
 
 
Figure 2.9 Schematic representation of Plasmodium falciparum detection assay using SPR based 
on DNA self-assembly and AuNPs amplification 
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Figure 2.10 Sensorgrams from a two-step SPR experiment of 0.1 μM target DNA with HCR 
molecules H1 and H2 for linear DNA amplification strategy and AuNPs signal enhancement. 
 
 
 
Figure 2.11 Sensorgram from a two-step hybridization, for 1.0 nM target DNA concentration  
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2.3.8 Sensitivity of detection in buffer medium 
To evaluate the analytical performance of our SPR biosensor using either HCR or 
AuNPs, the angle shifts from different concentrations of target DNA were measured 
following a two-step reaction. On the experiment channel, target DNA from 0.1 nM to 1.0 
μM were injected on separate experiments; non target DNA was injected in the control 
channel in order to assess non-specific binding. Increasing amounts of target DNA led to a 
proportional increase in the SPR signal, the sensorgrams and calibration curves are shown 
in Figure 2.12, after (A) HCR and (B) AuNPs amplification. The calibration curve for HCR 
showed a linear correlation from 1.0 nM to 0.1 μM, with R2 value of 0.9927. Because the 
SPR signal produces a systematic amount of noise, any shift below 0.02o is not meaningful 
therefore was not included in the calibration curve. In the case of AuNPs, the resonance 
angle shift reached a plateau after 0.1 μM (small insert). The curve was re-plotted to show 
the dynamic range from 0.1 nM to 0.1 μM and an R2 value of 0.9719 was obtained. From 
these results, we determined the amplification method by AuNPs is ten times higher than 
HCR.  
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Figure 2.12 SPR sensorgrams and calibration curves for (A) (B) HCR and (C) (D) AuNPs 
amplified detection of Plasmodium falciparum DNA. The curves from a to b represent 0.1 nM, 1.0 
nM, 10 nM and 0.1 μM, respectively. 
 
2.3.9 Analysis of detection in complex media 
To further evaluate the biosensor’s performance in complex media to mimic clinical 
samples, the target DNA was spiked into blood plasma (Figure 2.13, step 1a) instead of the 
buffer; all further steps were performed as described previously. Two control experiments 
were conducted to assess if using complex media will compromise the assay. First, we 
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assessed the non-specific binding in the absence of target DNA. The sensorgrams show 
that there is an angle shift of 0.1o on the channel injected with plasma, due to the proteins 
and other components that non-specifically bind on the sensor surface, while on the buffer 
channel the signal remains at baseline as no binding occurred. However, after AuNPs 
amplification step, no significant difference between both channels was observed, showing 
that the assay is not compromised by the complex components. In the second control 
experiment (Figure 2.14), both channels were spiked with 0.1 μM target DNA, however 
only one channel was injected with H1 and H2. Subsequently, after streptavidin was 
introduced only the channel with HCR displayed a signal increase and the same was 
observed after AuNPs amplification. No binding was observed on the channel without H1 
and H2 due to lack of biotin, preventing binding of streptavidin and biotinylated AuNPs. 
 
 
            Figure 2.13 Control experiment - No target DNA in samples 
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        Figure 2.14 Control experiment - No H1 and H2 in control channel 
 
2.3.10 Sensitivity of detection in blood plasma 
In clinical diagnosis of Malaria, the blood of suspected patients is drawn and 
brought to the lab for several tests including the blood film microscopy, RDTs or PCR. 
The blood film test being the main method used to spot and count malaria parasites in blood 
would usually takes 1-3 days and the process is repeated for the patients during treatment, 
until the result becomes negative. This clearly signifies the need for more sensitive, fast 
and early detection, before the patient reaches a dangerous untreatable level of this disease. 
To show the feasibility of this biosensing strategy in clinical application, we compared the 
biosensor performance when tested in blood plasma versus in buffer samples. Here, SPR 
measurements using plasma sample were conducted and the sensorgram is shown in Figure 
2.15. Briefly, the sensor chip incubated with capture DNA was left in running buffer for 
30 min before the plasma spiked with target DNA was injected (step 1a). In the control 
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channel, the same volume of buffer is spiked into plasma, while the other steps are identical 
to the experiment channel. As seen in both channels, there is a large SPR increase after 
injection of plasma due to a high refractive index of the bulk solution, after reaching a 
plateau we incubated the solution for 90 min. After the running buffer was turned on, the 
signal decreased but did not return to baseline due to binding of other components in the 
plasma. The subsequent injections were H1 and H2, followed by streptavidin and the 
biotinylated AuNPs. The experiments were repeated with different concentrations of target 
DNA, and Figure 2.16A shows that the resonance angle increased gradually as the target 
DNA concentration increased from 0.1 nM to 0.1 μM after the final rinse. For all 
sensorgrams only the experiment channel showed a large increase of signal after AuNPs 
amplification. To compare sensitivity with the buffer sample, calibration curves of both 
conditions are plotted in the same graph shown in Figure 2.16B. The graph shows the 
sensitivity of detection in blood plasma is comparable to buffered sample, that this method 
has great potential for clinical application with further improvement. 
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            Figure 2.15 Sensorgram of target DNA spiked in plasma 
 
 
 
Figure 2.16 Sensorgrams of different concentration of target DNA spiked in plasma. (A) resonance 
change after AuNPs amplification. The curves from a to b represent 0.1 nM, 1.0 nM, 10 nM and 1 
μM, respectively. (B) Calibration curve  
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2.3.11 Comparison to other SPR malaria biomarkers and malaria DNA biosensor 
Although many biosensors have been developed for malaria detection, most of the 
published works use enzymatic protein biomarkers such as Plasmodium falciparum 
histidine rich protein II (PfHRP-II or HPR-II), Plasmodium falciparum lactate 
dehydrogenase (PfLDH) and the parasite waste product such as hemozoin.12 To date, very 
few biosensors have been developed for molecular detection of the parasite’s DNA and the 
reasons are very clear, DNA that has to be extracted from blood, while the other biomarkers 
are abundantly present in blood and urine of infected patients. However, the detection 
method using biomarkers is not sensitive to low parasite density and can only be detected 
at least 7 days after the parasites are transferred to the human blood stream. This means 
that the current methods are not effective for early detection of Malaria, even the most used 
diagnostic like RDTs. Thus, the use of DNA as a new biosensor target allows highly 
sensitive and low limit of detection, which means the disease can be detected at an earlier 
stage of infection.  
An SPR based biosensor has the advantage of highly sensitive detection for many 
biomolecules. In the development of malaria biosensors, we grouped the sensors into two 
categories based on the target biomarkers; non-DNA and DNA target biomarkers. From 
the literature, we found SPR biosensors have been developed using heme (a toxin released 
by the parasites)53 and the retromer protein complex,54 and PfHRP-II.55 During these 
experiments the sensing antigens were recognized using apo-hemoglobin and antibodies, 
and the binding occurred in buffered media. For all biosensors, the antigens were prepared 
in labs and not extracted from actual clinical sample. This is understandable as SPR chips 
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are prone to surface fouling and the measurement produces a very large non-specific 
binding signal when complex media such as blood, plasma, serum and urine are used. 
Although this interference from complex media seems to hinder the progress of SPR for 
clinical application, the use of undiluted complex media with SPR has been 
demonstrated.56 Recently, our group has reported an antifouling sensor surface utilizing a 
supported lipid bilayer when used with human serum and plasma.57  
In the development of Malaria DNA based biosensors we did not note any previous 
research using SPR. Nevertheless, other biosensing methods were found, such as Malaria 
DNA detection by frequency and phase change using QCM13, 14 and Mach-Zehnder 
Interferometer (MZI).58 In these methods, DNA was extracted from patient blood samples 
and from malaria parasites cultured in lab. In the QCM biosensor, the extracted DNA was 
amplified using PCR before the target DNA is allowed to bind with the immobilized 
complementary probes.  For the MZI biosensor, the DNA amplification step was done on 
the sensing chip at 37oC. Again, for both methods actual clinical sample was not used 
during the detection step. However, the results are a good indicator that a biosensor for 
detection of malaria at the molecular level is more sensitive than microscopy and can move 
us towards the sensitivity achieved by RDTs and PCR, with more advance features than 
those conventional methods including detection of more than one Plasmodium species at 
the same time.  
In our SPR biosensor, the detection and amplification occur on the same surface, via 
simple DNA binding and hybridization at room temperature, before further amplification 
using AuNPs. The measurement was done in buffer and undiluted blood plasma, and we 
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achieved detection as low as 1 picomolar compared to micromolar detection from the QCM 
method. The DNA amplification using HCR method is also versatile for other biosensing 
detection of low abundance DNA, for example in biochemical studies, forensic 
investigations and pathogen detections.31 However, our method lacks comparison to other 
clinical methods such as microscopy, RDTs and PCR, which is useful as a benchmark to 
any developed biosensor. In addition, the specificity of our biosensor against other 
Plasmodium species was not evaluated. While we did not use blood sample from infected 
patients, using undiluted blood plasma can mimic actual clinical diagnostics and further 
improvement can be made from this initial data. Nonetheless, our method has several 
advantages : it eliminates the need to pre-amplify the target DNA using complex 
instruments, the detection and amplification result is analyzed on the same platform, it 
provides real-time measurement of all binding interactions, is universally applicable to 
other detection of DNA and has potential for detection using clinical samples and to be 
developed into a portable instrument. 
2.3.12 Potential of our biosensor for clinical detection and integration into a portable 
instrument 
An ideal DNA biosensor for clinical application, not only for malaria but for other 
diseases, must be comprised of 1) a sample preparation chamber where the biofluid of 
interest is either diluted or separated, and where the DNA can be extracted, 2)  a sensing 
chip immobilized with the recognition element, 3) an efficient binding mechanism between 
the target DNA and the recognition element, 4) a transducer system that recognizes the 
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binding and transforms the biomolecule interactions into a measurable signal, 5) a proper 
amplification method (if required) for the sensitivity to be in a useful clinical detection 
range, and 6)  data processing that informs the user of the detection result for proper 
diagnosis and prognosis to be made based on the patient sample. The challenge is however 
to fully integrate and miniaturize all the above, in a cost-effective way, into a simple 
automated device for it to be field deployable or for use in point-of-care diagnostic.  
For our SPR biosensor to be integrated as the main sensing platform in a portable 
diagnostic equipment; important parts of the platform are a prism, a gold chip and a flow 
cell with at least two channels. A microfluidic chamber for sample collection, sample 
dilution, components separation and DNA extraction are needed before the extracted target 
DNA can be introduced into the SPR flow cell.  A sample-processing module that is able 
to perform the task has been developed,58 although the system is not fully integrated with 
the sensing part, the system shows capability to extract DNA that was previously spiked 
into a blood sample. 
Another consideration is whether the sensing chip is reusable or one-time use, 
although the latter is not preferable due to cost, but a very good antifouling surface or 
cleaning procedure has to be established between usages when applying a single chip for 
multiple measurements. A multiplex system for detection of multiple Plasmodium species 
is desirable, therefore the target-recognition element has to be highly specific and multiple 
probes have to be immobilized on the surface. Another factor to consider is a calibration 
process to avoid signal drift over time and to make sure results are accurate and 
reproducible; this could include auto-calibration or manual calibration with a known 
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sample, and in our case the calibration includes a shift after subtracting the non-specific 
binding. Finally, we need a data processing system that interprets the binding signal into a 
digital electronic signal that is proportional to the concentration of target DNA and then 
translates the result to a user interface showing positive or negative detection of malaria 
parasites from the patient sample.  
 
 Conclusion  
In this study, we developed a simple and sensitive SPR DNA biosensor for a 
molecular level detection of Malaria that is vital for early diagnosis of this disease. We 
showed that the DNA detection coupled with HCR and gold nanoparticles amplification 
strategies increase the sensitivity, thus enabling picomolar range of detection.  Compared 
to existing methods, our biosensor has several advantages, as discussed above. Although 
actual clinical samples were not used, we performed a systematic evaluation using human 
blood plasma to access the non-specific bindings that is a known challenge in biosensor 
especially SPR.  
Our future direction includes evaluation of sensing capability and selectivity in a 
clinical standard requirement, using infected blood samples instead of the spiked blood 
plasma. More evaluations are needed to compare with conventional methods such as 
microscopy, RDTs and PCR. Overall, with our findings and from other existing studies in 
DNA biosensor, the future of a complete biosensor system for clinical diagnosis is brighter 
now than ever, not only for Malaria but also for other applications that could benefit from 
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this development. Future research should also be looking into integration of a microfluidic 
or lab-on-a-chip for sample preparation, and miniaturization of the detection and 
transduction system. 
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 Nanoparticle Enhanced SPR Detection of Cholera 
Toxin (CT) on an Antifouling Lipid Membrane in Undiluted Serum 
 
ABSTRACT 
Countless development of biosensors has been reported with the aim to make the 
devices readily available for clinical diagnostics. However, the analysis of clinically 
relevant biomarkers in complex matrices, such as human blood serum and plasma, has 
always been a challenge. These samples contain high concentration of proteins and other 
components that not only risks false analysis from non-specific binding but also causes 
surface fouling from the absorption of the unwanted protein components. Here we present 
a novel surface chemistry with antifouling property and an ultrasensitive detection with 
nanoparticle enhancement strategy, universal enough for many biomarker targets and other 
sensing methods. In this biosensor design, we utilized a biomimetic interface of supported 
lipid bilayers (SLBs) formed over a protein A coated gold chip.  The membrane formation 
was followed by a subsequent interaction of analytes spiked in undiluted human serum to 
the capture element on sensor surface and the real-time binding was analyzed by Surface 
Plasmon Resonance (SPR) spectroscopy. Using Cholera Toxin (CT) as our proof-of-
concept, we achieved a sensitive detection after a complete removal of non-specifically 
bound components in human serum, as monitored by SPR measurement. As protein A 
allows for an orientation-controlled binding to variety of antibodies, this interface unlocks 
more potential of antifouling applications to a wider biosensing field, including 
immunosensing. Therefore, in addition to CT, we tested the surface for detection of 
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Immunoglobulin G (IgG). For both analytes, the SPR signal was enhanced using gold 
nanoparticles allowing detection in low concentrations without compromising the 
antifouling property of the sensing surface. 
 
 Introduction 
Currently, there are many issues around the world related to human health and 
diseases, that require a good detection and diagnosis system. An effective and early 
diagnosis is needed to provide proper treatments and for monitoring of diseases.  In the 
case of infectious diseases, early detection is crucial to prevent fatality and a mass outbreak. 
For this reason, many ongoing developments in biomedical analysis are moving towards 
better diagnosis tools not only for the standards laboratory diagnosis but for more advanced 
clinically relevant devices. This includes for detecting diseases caused by bacteria (e.g. 
sepsis,1 urinary tract infections,2 sexually transmitted infections3), mycobacteria (e.g. 
tuberculosis4), virus (e.g hepatitis5, HIV6), fungi (e.g. candidiasis7) and parasite (e.g. 
malaria8). For complex diseases such as cancer, pathological methods such as tissue biopsy 
are often needed to confirm a cancer diagnosis. However, by the time patients are 
diagnosed with breast, lung, colon, or ovarian cancer, more than 60% already have cells 
metastasize in other art of their body.9  
Therefore, there is a need for highly specific and sensitive detection method that 
recognize the early sign of a diseases through their biomarkers.10, 11 The biological 
biomarkers (biomarkers) are defined as the “cellular, biochemical or molecular alterations 
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that are measurable in biological media such as human tissues, cells, or fluids.”12 In 
particular, the disease biomarkers, can be proteins and protein fragments, DNA/RNA, or 
specific small molecules, are presence in the patient’s body at a specific time and can be 
different types at different stages. Therefore, a biomarker can be used as a measurable 
indicator of a presence or severity of the diseases. Direct biomarker analysis within blood 
and serum holds great promise for monitoring of patient homeostasis, disease state, and 
drug or environmental exposure, provided that it can be performed in a sensitive, 
reproducible, and efficient fashion.13 Some examples of common biomarkers are presented 
in Table 3.1. 
Table 3.1 Common disease biomarkers 
 
 
Biosensors technologies are widely employed as devices for diagnosis and for 
monitoring of diseases progression, with the advantages of being simple, sensitive and 
rapid detection, require small sample volume, and have shown potential in miniaturization 
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to a portable instrument. Surface Plasmon Resonance (SPR) is an example of surface 
sensitive biosensor, utilizing optical detection platform capable of measuring biomolecular 
interactions in real time and recent developments resulted in the construction of small 
portable devices for field use.14 SPR has been successfully applied in the analysis of a 
number of clinical targets15,16 including various disease biomarkers,17-20 cancer 
biomarkers,21  hormones,22 and therapeutic drugs.14, 23, 24 
However, the analysis or direct detection of biomarkers are carried out in a complex 
media such as blood serum or plasma, as opposed to buffered solution as commonly 
practiced in biosensors analysis. Human body fluids contain a wide range of complex 
proteins that causes a non-specific accumulation of biomolecules onto a biosensor surface, 
which hinders the progress of biosensors, not only SPR, towards accurate measurements 
necessary for a clinical application. Therefore, the design of novel interfaces that minimize 
these non-specific interactions is of the utmost importance.  
Various surface chemistries intended to minimize these non-specific interactions 
and the resulting background signals have undergone aggressive development.25, 26 Sample 
dilution may be performed to minimize the concentration of non-target molecules, though 
this strategy correspondingly minimizes target concentration and is not always practical.27 
Surface blocking with adsorbed, non-reactive compounds (e.g., bovine serum albumin, 
Tween-20, and commercially available mixtures) has seen many notable successes for a 
variety of clinical targets within human bodily fluids.28-32 Integrated chemical 
derivatization strategies may reduce assay time further through elimination of these 
blocking steps, and have included the use of polysaccharides (e.g., carboxymethylated 
 78 
dextran),26, 33 polymeric monolayers (e.g., polyethylene glycol),25, 26, peptides,34 ionic 
liquids,35 and zwitterionic compounds.36, 37 The latter category covers a wide variety of 
molecules, though phosphocholine based interfaces have demonstrated particularly notable 
successes in reducing non-specific adsorption onto glass and gold surfaces.37-40 As a major 
component of the eukaryotic cellular membrane, this surface moiety is not only capable of 
mimicking this biological environment, but is remarkably resistant against fouling from 
extracellular constituents.37, 40 
We have previously reported on the utility of supported lipid membranes for a 
variety of biosensing applications,41-44 including the development of a membrane cloaking 
method for carrying out indirect immunoassays in undiluted animal serum.45 For that 
experimental design, a supported lipid membrane was formed over an antibody 
functionalized gold surface, which was removed along with all superimposed serum 
contaminants using a mild surfactant once the crude sample was allowed to interact with 
the sensor.  With all nonspecific components stripped away, the remaining signal could be 
attributed to the target compound, and furthermore, the antibody-antigen complex 
remained accessible to further signal enhancement mechanisms. 
In addition to the surface fouling from carrying out the analysis in complex media, 
a specific interaction between the recognition element and the analyte is highly sought, as 
less effective binding caused by a steric hindrance or random orientation of the 
biomolecules resulted in signal interference and sensitivity reduction. For the attachment 
of biomolecules using the traditional coupling techniques such as electrostatic adsorption 
or covalent crosslinking (e.g., using EDC/NHS, BS3, etc.), as is common practice, the 
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attachment efficiency and orientation are dependent upon accessible functional groups and 
localized areas of charge on the biomolecules surface, which are highly variable. For 
example, in a non-ideal scenario of immunosensing, the antibody of interest may be 
attached with the fragment antigen-binding (Fab) region unexposed, or in worst case, not 
attached at all, rendering the constructed sensor incapable of measuring its intended target. 
Oriented immobilization of antibodies to a sensor surface can be universally achieved 
through the use of proteins with Fc (fragment crystallizable) binding domains such as 
protein A, G, or L.46-48 However, given the broad affinity of these proteins for nearly all 
immunoglobulins, they represent a class of functionalization techniques extremely prone 
to surface fouling, and are therefore seldom seem in biosensing applications that are carried 
out in undiluted biofluids.   
Herein we build upon this strategy, to further improve the practical utility supported 
lipid membranes as an antifouling surface for analysis in complex matrices through 
investigation of different lipid constituents on a protein A coated sensor surface for an 
orientation controlled biosensing (Figure 3.1). Surface plasmon resonance (SPR) was 
chosen for characterization and optimization of this interface,49 since as a label-free optical 
detection method, all species bound to the sensor surface can be detected, whether they are 
labelled or unlabeled, target or contaminant.50 Fluorescence microscopy and 
photobleaching assays were conducted to better understand the interactions between these 
lipids and the underlying protein A coated surface.  
As a proof-of-concept, we utilized this interface for the detection of Cholera toxin 
(CT), a protein complex secreted by the gram-negative bacterium Vibrio Cholerae 
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responsible for the massive, watery diarrhea of Cholera infection in the small intestine.51, 
52 CT belongs to the larger family of AB toxins, is comprised of a 27 kDa A subunit and 
five copies of B subunit each weighing 11.5 kDa (Figure 3.1C).53  Cholera is a highly 
infectious disease that spread mostly by unsafe water and contaminated food. Natural 
disasters and poor sanitation are major players in the spread of cholera without proper 
management of patients and their waste.54 
Our results demonstrated a sensitive detection of CT in undiluted blood serum that 
is uncompromised when compared to buffer samples. Further sensitivity was achieved with 
enhanced detection with AuNPs enables detection in ultralow concentrations. Given the 
universal nature of protein A, it can be envisioned that this surface could be translated to a 
variety of other clinical sensing applications using SPR and adjacent biosensing 
technologies. 
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Figure 3.1 (A) Structures of the lipids investigated based on varied charges. (B) Crystal structure 
and electrostatic potential map of protein A. Blue is indicative of negatively charged areas, while 
red is indicative of positively charged areas. (C) Cholera toxin (CT) crystal structure showing the 
A and B subunits (Edited from ref. 53) 
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 Experimental Section 
3.2.1 Materials and reagents 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-
sn-glycero-3-ethylphosphocholine (EPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
(1’-rac-glycerol) (POPG), and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-
nitro-2-1,3-benzoxadiazol-4-yl) (NBD-PE) were obtained from Avanti Polar Lipids 
(Alabaster, AL). Silane-PEG-Maleimide was obtained from Nanocs (New York, NY). 
Thiolated recombinant protein A was obtained from Protein Mods (Madison, WI). 
Functionalized oligonucleotides were obtained from Integrated DNA Technologies 
(Coralville, IA). Anti-Mouse IgG (rabbit polyclonal purified IgG) was obtained from EMD 
Millipore (Temecula, CA). Biotinylated antibodies were conjugated in house using the EZ-
LinkTM Sulfo-NHS-Biotin labeling kit obtained from Thermo Fischer Scientific (Waltham, 
MA). All other reagents were obtained from Millipore-Sigma (St. Louis, MO). 
3.2.2 Lipid vesicle preparation 
Stocks POPC (5 mg / mL), EPC+ (5 mg / mL), and POPG− (10 mg / mL-) were 
diluted in chloroform to the designated concentrations, and stored at -80 °C.  Appropriate 
amounts of these stock solutions were aliquoted into glass vials and dried under nitrogen 
to form thin lipid films, which were then stored in a vacuum desiccator overnight to remove 
any residual solvent. The dried lipids were resuspended in 1× PBS (10 mM Na2HPO4, 1.8 
mM KH2PO4, 137 mM NaCl, 2.7 mM KCL, pH 7.4) to a final concentration of 1 mg / mL 
followed by vigorous vortexing and bath sonication for 30 min. This solution was extruded 
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through a polycarbonate filter (Whatman, 100 nm) to produce small, unilamellar vesicles 
of uniform size. All lipid vesicle suspensions were stored at 4 °C and used within one week 
of preparation. The final centration of 1 mg / mL is above the critical micelle concentration 
(CMC) of the lipids and high enough to form bilayer vesicles.  
3.2.3 Preparation of gold surrogate and gold surface for fluorescence microscopy 
Glass coverslips were cleaned with boiling Piranha solution (3:1 H2SO4 / 30% 
H2O2) for 2 h then thoroughly cleaned with water and ethanol before drying with 
compressed air.  The coverslips were then submerged in a 1 mg / mL solution of Silane-
PEG-Maleimide in ethanol overnight at room temperature. After cleaning with ethanol and 
drying with compressed air, a 10 µg / mL solution of thiolated protein A in 10 mM PBS 
was added to the surface for 2 h at room temperature.  Coverslips were then washed with 
distilled water and dried under a stream of N2 before being coated with a 1 mM solution of 
3-mercapto-1-propanol (MPO) in 10 mM PBS for 1 h at room temperature. After washing 
with distilled water and drying with N2, lipid vesicles at 1 mg / mL were added to the 
surface in PDMS wells for 1 h and protected from ambient lighting. Lipids were prepared 
according to a standard protocol and consisted of either EPC, POPC, or a 1:1 mixture of 
EPC / POPC with 2% (w/w) NBD-PE, as specified in the main text. The coverslips were 
then rinsed thoroughly with distilled water, taking care not to expose the lipid surfaces to 
air, and then mounted onto glass slides.  For fluorescent measurements of lipids not formed 
over a protein A surface, the lipids were directly added to the piranha treated glass 
coverslips. Fluorescence microscopy images were taken using an inverted Leica TCS SP5 
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II (Leica Microsystems, Buffalo Point, IL) using the 488 nm Argon laser line and a 40× 
objective, and FRAP analysis was carried out by photobleaching for 500 ms and 
monitoring the recovery using the FRAP wizard on the LAS AF software (Leica 
Microsystems, Buffalo Point, IL). The mobile fractions (ß) and diffusion coefficients (D) 
were obtained using a previously reported protocol.55 Briefly, these coefficients provide 
information about the mobility of a fluorescent molecule in a defined compartment, in 
practical the fluidity of a membrane formed naturally on a surface, and how fast the 
molecule is moving due to active transport in diffusion.56 
For fluorescent measurements of EPC lipids with human serum, the preparation 
was carried out in a sample reservoir made of PDMS mold placed on a cleaned glass slide 
deposited with a thin layer (~ 4 nm) of gold. Following the same procedures in preparing 
Protein A, MCH and EPC with 2% (w/w) NBD-PE coatings as described above, an 
additional step is carried out following the rinse after lipid incubation.  The surface was 
coated with undiluted serum for 1 hour before the final rinse and then the surface was 
covered with a cover slip to prevent drying.  
3.2.4 Gold nanoparticle conjugation 
Gold nanoparticles were prepared using a standard citrate reduction. Briefly, a 12.5 
mM solution of HAuCl4 was dissolved in 500 mL of distilled water in glassware previously 
cleaned with aqua regia (3:1 HCl to HNO3). This solution was heated until boiling with 
vigorous stirring, then a 30 mM solution of sodium citrate tribasic dihydrate was added, 
and the solution boiled for another 15 min before being allowed to cool to room 
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temperature. The size of gold nanoparticles was determined from UV-Vis method and is 
the core diameter of the gold nanoparticles prior to functionalization.57 These nanoparticles 
were functionalized with thiolated oligonucleotides consisting of poly-thymine and 
biotinylated poly-thymine in a 1:1 ratio according to a protocol previously reported in our 
group.58 The as-synthesized gold nanoparticles were concentrated by a factor of 3 before 
the addition of 2.5 nmol DNA (100 µM, H2O) to 1 mL of concentrated gold nanoparticles.  
Immediately, 20 µL of citrate-HCL (500 mM, pH 3.0) was added and the solution vortexed 
before the addition of 10 µL of 10% (v/v) Tween 20.  Finally, the NaCl concentration was 
increased to 1 M and the nanoparticles were incubated overnight at 4 °C. Excess reagents 
were removed from the nanoparticle solution by centrifugal filtration (Amicon, MWCO 50 
kDa), and the resulting conjugates were stored at 4 °C. 
3.2.5 Gold sensor fabrication and functionalization 
BK-7 glass microscope slides (Corning, Painted Post, NY) were cleaned with a 
boiling piranha solution (3:1 H2SO4 and 30% H2O2) for 2 h then subsequently rinsed with 
water and absolute ethanol before drying under compressed air.  A 2 nm layer of chromium 
(0.5 Å s-1) followed by a 50 nm layer of gold (1.0 Å s-1) was deposited onto the glass slides 
using electron-beam evaporation (Temescal, Berkeley, CA) at 5×10-6 Torr in a Class 1000 
cleanroom facility (UCR Center for Nanoscale Science & Engineering). These gold sensor 
chips were rinsed with ethanol and dried under compressed air before being coated with 10 
µg / mL thiolated protein A (Protein Mods, Madison, WI) in 1× PBS for 2 h at room 
temperature (ca. 23 °C), followed by a 1 mM solution of 3-mercapto-1-propanol (MPO, 
 86 
Millipore-Sigma, St. Louis, MO) in 1× PBS for 1 h at room temperature.  The sensor chips 
were rinsed with nanopure water (≥18 MΩ·cm, Barnstead E-Pure) and dried under a 
nitrogen stream after each step before final storage at 4 °C. Nanoglassified gold sensor 
chips were prepared by depositing a thin layer of silica (ca. 2-4 nm) via plasma-enhanced 
chemical vapor deposition using a Unaxis Plasmatherm 790 (Santa Clara, CA) directly 
after electron-beam evaporation of gold, and these chips were not subject to any further 
functionalization.43 
3.2.6 SPR analysis of lipid deposition and fouling 
Surface plasmon resonance (SPR) spectroscopy was conducted at room 
temperature on a NanoSPR5-321 (NanoSPR, Addison, IL) using 1× PBS as the running 
buffer set to a flow rate of 5 mL h-1 (ca. 83 μL min-1) unless otherwise noted. Lipid 
deposition was carried out by injection of 1 mg / mL lipid vesicles into the instrument and 
the minimum angle was tracked over 1 h under zero flow conditions. After a 10 min rinse 
with 1× PBS, undiluted human serum (male from AB plasma, Millipore-Sigma) or plasma 
(pooled, Millipore-Sigma) was injected and allowed to interact with the surface under zero 
flow for 30 min, before a final 15 min rinse with PBS. 
For analysis of mouse immunoglobulin (IgG) and cholera toxin (CT) within spiked 
human serum and plasma, 100 µg / mL of capture antibody (rabbit anti-mouse IgG or rabbit 
anti-CT, Millipore-Sigma, St. Louis, MO) was incubated for 1 h. This was followed by 
lipid vesicle deposition as described above, and the surface was subsequently interacted 
with human serum or plasma spiked with the target antigen, mouse IgG or CT. All steps 
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were separated by a 10 min PBS rinse with the exception of the post-sample rinse, which 
was extended to 30 min. Detection antibodies were introduced at a concentration of 10 µM 
for 1 h. For the nanoparticle enhanced detection, the same protocol was followed, with the 
addition of 100 µg / mL streptavidin, followed by 1 nM of 30 nm biotinylated gold 
nanoparticles (bT20/AuNPs).58 
3.2.7 Fluorescence microscopy and fluorescence recovery after photobleaching (FRAP) 
Fluorescence microscopy images were generated on an inverted Leica TCS SP5 II 
(Leica Microsystems, Buffalo Point, IL) using the 488 nm Argon laser line in conjunction 
with a 40× objective (N.A. 1.1). Photobleaching for 500 ms and monitoring of fluorescence 
recovery within defined regions of interest were performed using the LAS AF software 
package (Leica Microsystems, Buffalo Point, IL). Mobile fractions (ß) and diffusion 
coefficients (D) were determined using the methods of Axelrod and Soumpasis as 
previously reported.41, 59, 60 
3.2.8 SPR analysis of human serum and plasma on lipid bilayers   
BK-7 glass microscope slides were cleaned with boiling Piranha solution (3:1 
H2SO4 / 30% H2O2) for 2 h then thoroughly cleaned with water and ethanol and dried with 
compressed air.  A 2 nm layer of chromium followed by a 50 nm layer of gold was 
deposited onto the glass slides using e-beam evaporation. These gold chips were washed 
with ethanol and dried under compressed air before being coated with 10 µg / mL thiolated 
protein A in 1 x PBS for 2 h at room temperature (ca. 23°C), followed by a 1 mM solution 
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of 3-mercapto-1-propanol (MPO) in 1 x PBS for 1 h at room temperature.  The chips were 
washed with distilled water and dried under a stream of N2 between the protein A and MPO 
conjugation and before storage at 4 °C. Alternatively, nanoglassified gold chips were 
prepared by depositing a thin layer of SiO2 using plasma-enhanced chemical vapor 
deposition (PECVD), and these chips were not subject to any further functionalization 
before analysis by SPR. For both protein A / MPO coated and nanoglassified gold chips, 
lipid formation was carried out by the injection of 1 mg / mL lipid vesicles into the SPR 
instrument and the minimum angle tracked over 1 hour under stopped flow conditions. 
After a 10 min wash with 1 x PBS undiluted human serum or plasma was injected and 
reacted with the bilayers under stopped flow for 30 min, before a final 15 min wash step 
with PBS. 
3.2.9 Analysis of analytes spiked human serum and plasma   
Gold chips were functionalized with 10 µg / mL thiolated protein A and 1 mM MPO 
solution according to the protocol previously described. In this experiment all biological 
components were diluted to concentration with 1 x PBS (10 mM Na2HPO4, 1.8 mM 
KH2PO4, 137 mM NaCl, 2.7 mM KCL, pH 7.4) and was carried out at room temperature 
(c.a 23°C). 100 µg / mL of anti-CT was first incubated on the protein A surface for 1 hour. 
Following washing step with 1 x PBS, 1 mg / mL EPC lipid vesicles, human serum spiked 
with 10 µg / mL CT and 1µM anti-CT were injected and incubated for 1 hour. After the 
final washing step, the binding was monitored and quantified to obtain the angle shift. For 
the nanoparticle enhanced detection of CT, 1 µM biotinylated anti-CT was added instead 
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of anti-CT after the washing step following serum spiked with 0.05 µg / mL CT. The 
injection steps were continued with 100 µg / mL streptavidin, followed by 1 nM of 25 nm 
biotinylated AuNPs. The steps were repeated with different concentration of CT for 
constructing calibration curves without AuNPs and with AuNPs enhancement. 
For analysis on IgG, 100 µg / mL of Anti-mouse IgG diluted in was incubated on 
the protein A surface for 1 hour and the binding monitored using SPR.  This was followed 
by the injection and incubation of 1 mg / mL EPC lipid vesicles (1 hour), human serum or 
plasma spiked with 10 µg / mL mouse IgG (1 hour) and 1 µM biotinylated anti-mouse IgG 
(1 hour).  All steps were separated by a 10 min PBS wash with the exception of the wash 
after the human serum which was extended to 30 min. For the nanoparticle enhanced 
detection of IgG in human serum, the same protocol was observed, with the exception of 
the Anti-IgG being added to the surface offline before analysis, and the addition of 100 µg 
/ mL streptavidin, followed by 1 nM of 30 nm biotinylated AuNPs. 
3.2.10 Comparison to the traditional SAM surface 
This was carried out following a basic protocol previously reported by our group,61 
with necessary changes made for the detection of the antibodies within this paper. Gold 
chips were fabricated with a 2 nm layer of chromium and 50 nm layer of gold via 
electrodepostion, washed with ethanol, and dried under compressed air. Next the chips 
were soaked in 1 mM of 1-mercaptoundecanoic acid (MUA) (in ethanol) solution overnight 
to form a self-assembled monolayer with carboxyl functional groups on the surface. The 
chips were washed with deionized water and dried under a stream of N2.  In the SPR 
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instrument, a mixture of 0.4 M EDC and 0.1 M NHS was injected into the flow cell and 
incubated for 30 min. After a 15 min wash with PBS, 100 µg / mL anti-cholera toxin (anti-
CT) was injected and incubated for 30 min to allow formation of covalent amide linkages. 
Following this, passivation of the unused activated carboxyl groups was carried out by 
injecting a 4 mM PEG-amine and incubated for 20 min. Next 25 µg / mL of CT was injected 
and incubated for 30 min to allow binding with the capture anti-CT. Finally, 100 µg / mL 
of anti-CT was injected to amplify the detection signal, then incubated for 30 min before a 
30 min washing step. All injection steps were separated by a 15 min washing with PBS 
unless different washing time is specified. 
 
 Results and Discussions 
3.3.1 Formation of an antifouling lipid membrane over Protein A 
The use of protein A in immunoassay design carries the distinct advantage of being 
able to provide a site for optimal orientation-controlled attachment of antibodies, with the 
Fc (fragment crystallizable) region bound by protein A and directed toward the sensor 
surface, and the Fab (fragment antigen-binding) region extending into the sample matrix.46 
Leveraging this capability for the analysis of crude samples would present a powerful tool, 
provided that levels of nonspecific binding are controlled. We previously developed a lipid 
membrane interface for antibody-based detection in undiluted animal serum, which was 
formed over a gold surface functionalized with a mixed self-assembled monolayer (SAM) 
of cysteamine and 3-mercapto-1-propanol (MPO).45 Building upon this design, initial 
studies retained use of MPO as a spacer molecule while the cysteamine constituent was 
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substituted with protein A. Protein A was first deposited onto the gold surface at a 
concentration of 10 µg / mL for 2 h, and the interstitial area was backfilled with MPO. 
Introduction of undiluted human serum to this interface resulted in massive angular 
resonance shifts (Δθ = 0.73 °), indicative of high levels of nonspecific binding that could 
not be rinsed away by buffer or surfactant (Figure 3.2A), thereby necessitating the use of a 
blocking agent or barrier. A membrane of zwitterionic phosphocholine (POPC) was 
naturally favored for this task due to the molecule’s well-characterized antifouling 
properties and demonstrated increases in bioanalytical sensor performance.37, 62 However, 
when a suspension of POPC vesicles was introduced to the protein A/MPO surface, 
followed by serum, nonspecific binding remained unaffected compared to the surface 
without lipids (Figure 3.2B). As the angular resonance shift from lipid introduction 
appeared low (Δθ < 0.1 °) compared to previous SPR investigations of supported lipid 
bilayer formation (Δθ > 0.45 ° over silica/silicate nanofilms on gold),41, 43, 58 a low surface 
coverage of POPC was suspected to be the issue here, thus requiring confirmatory studies 
using a complementary analytical technique. 
Confocal fluorescence microscopy was employed to investigate the spatial 
distribution of fluorophore-tagged phospholipids over the protein A/MPO interface. A 
surrogate material was used in place of the gold SPR substrates, which consisted of a glass 
coverslip functionalized with a SAM of silane-PEG-maleimide (see Supporting 
Information for fabrication details). This surface provided an even monolayer of thiol-
reactive sites, analogous to gold, though circumvented the issue of fluorescent quenching 
by nonradiative energy transfer to the gold surface. Once protein A, MPO, and a suspension 
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of POPC vesicles containing a fluorophore-labeled constituent (2% wt NBD-PC) were 
applied as described above, the surface was kept submerged in an aqueous environment 
and imaged. From the image in Figure 3.2B, the distribution of fluorescence appears patchy 
and uneven, indicating that POPC vesicle adsorption was inefficient, thereby leaving large 
areas of the protein A/MPO surface exposed to incoming contaminants from the sample 
matrix. Utilization of these lipid membranes to combat nonspecific binding would require 
a more targeted approach in which lipid interactions with the underlying surface were 
discreetly considered. 
Although the formation of supported lipid bilayers via the fusion of small 
unilamellar vesicles (SUVs) is conventionally carried out over smooth, rigid, and 
hydrophilic surfaces,41, 43, 63 lipid membranes have also been formed over a variety of 
SAMs in which interactions with lipid headgroups were electrostatically favored.64, 65 
Given that the theoretical isoelectric point (pI) of protein A is ca. 5.4,66 the protein A/MPO 
sensor surface is expected to carry a net negative charge within our running buffer at pH 
7.4. Therefore, it was hypothesized that lipid vesicles exhibiting a net positive charge 
would be required for greater surface interaction strength toward forming a contiguous 
barrier. Indeed, when a new vesicle suspension consisting solely of a positively charged 
lipid, ethylphosphocholine (EPC+), was introduced to the protein A/MPO surface, 
resonance angular shifts increased by ca. 0.7 ° compared to POPC, suggesting that the 
surface was more completely coated with lipids (Figure 3.2C). This was confirmed by 
fluorescence microscopy of labeled (2% wt NBD-PC) EPC+ vesicles deposited on protein 
A/MPO, revealing a more complete and even distribution of fluorescence (Figure 3.2C). 
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Interestingly, upon introduction of human serum to the EPC+ laden surface, a lower angular 
shift was observed (Δθ = 0.5 °) compared to the untreated and POPC modified surfaces (Δθ 
= 0.73 °). This signal remarkably returned to the baseline EPC+ value post-incubation (1 
h) and a buffer rinse (10 min), suggesting that all serum contaminants can easily be 
removed without also having to strip away the membrane. The EPC+ lipids remain stably 
bound to the surface after this time, exhibiting no decrease in angular shift, which would 
be indicative of detachment or deterioration of the interface, even after an extended (2 h) 
rinse under a constant flow of buffer (Figure 3.3). The use of a mixed lipid vesicle 
suspension consisting of 50 % POPC and EPC+ was also investigated in an attempt to see 
if the overall charge could be reduced (Figure 3.4), though while the results were better 
than POPC alone, a fair amount of serum material remained on the surface after the buffer 
wash (Δθ = 0.34°). In an effort to more completely validate the idea that charge-matching 
between these lipids and the underlying surface is necessary for complete coverage, 
negatively charged POPG− vesicles were investigated for their antifouling properties. 
However, much like the POPC vesicles, a low (Δθ < 0.1 °) angular resonance shift was 
observed upon introduction of lipids to the surface, as well as a high (Δθ = 0.59 °) level of 
nonspecific binding from serum that could not be rinsed away under flow of buffer (Figure 
3.5). Therefore, tailoring the charge of these lipid vesicles to their underlying surface 
chemistry appears critical for enabling successful formation of a supported lipid membrane 
over protein A, in turn rendering it resistant to biofouling from human serum.  
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Figure 3.2 Schematic representations and corresponding data for the addition of undiluted human 
serum to a protein A/MPO surface (A), POPC over protein A/MPO (B) and EPC+ over protein 
A/MPO (C). Lipid vesicles (B and C) were injected (1) and incubated for 1 h, before the addition 
of undiluted human serum (2) for 30 min, followed by a PBS rinse (3) to remove any unbound 
components. Corresponding fluorescence micrographs depict distribution of POPC (B) and EPC+ 
(C), respectively, over protein A/MPO.  Scale bars represent 30 µm. 
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Figure 3.3 Sensorgram depicting an extended wash step on an antifouling lipid bilayer formed over 
the protein A/MPO gold surface. EPC was injected over the surface (1) and incubated for 1 h, 
followed by the injection of undiluted human serum (2) for 30 min, and finally a 2 h PBS wash (3) 
was carried out to assess stability of the membrane over time. 
 
 
 
 
Figure 3.4 Sensorgram depicting the extent of non-specific binding from human serum components 
onto lipid bilayers when the overall charge is reduced. Gold chips were coated with protein A and 
MPO according to the standard protocol. A solution of EPC lipid vesicle (black) or a 50% mixture 
of EPC and POPC were injected for 1 h (1), followed by undiluted human serum for 30 min (2), 
and a PBS wash (3). 
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Figure 3.5 Sensorgram depicting the extent of non-specific binding from human serum onto a gold 
chip modified with protein A, MPO and POPG.  POPG was injected over the surface (1) and 
incubated for 1 h, followed by the injection of undiluted human serum (2) for 30 min, and finally a 
PBS wash (3) was used to remove unbound serum components. 
 
 
3.3.2 Extension to undiluted human plasma 
Blood plasma is generally prepared by introducing anticoagulants to whole blood 
and centrifuging to collect the supernatant, requiring less technical expertise and 
considered less time consuming to separate than serum. Although it is a more complex 
medium, containing fibrinogen and other clotting factors that are absent from serum, a high 
interest in plasma profiling exists due to its comparatively facile preparation and higher 
reproducibility in the characterization of select metabolites and proteins.67-69 Given that the 
EPC+ lipid membrane over protein A/MPO demonstrated high antifouling activity against 
human serum, translatability to other crude fluids such as plasma presented a tantalizing 
possibility and was therefore investigated (Figure 3.6). High levels of non-specific 
interactions over the protein A/MPO surface were once again observed (Δθ = 0.72 °) when 
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undiluted human plasma was incubated over the surface in the absence of any lipids (Figure 
3.6A). This observation reiterates that although protein A is ideal for antibody orientation 
and ease of attachment, it does represent one of the more universally difficult surface 
chemistries to work with for clinical sample analysis. However, once EPC+ lipids have 
been deposited over this surface, non-specifically bound components from plasma can be 
completely removed under a buffer flow, in an identical manner to that of the serum 
samples (Figure 3.6B). Therefore, either matrix should be compatible for immunosensing 
over this protein A/MPO surface chemistry in conjunction with the EPC+ lipid barrier. 
 
 
 
Figure 3.6 Surface plasmon resonance sensorgrams demonstrating the extent of non-specific 
binding from undiluted human plasma injected over a protein A/MPO coated gold surface (A) and 
a protein/MPO surface coated with an EPC+ lipid barrier (B). 
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3.3.3 Performance-affecting considerations  
With successful EPC+ deposition and antifouling activity, we sought to define other 
parameters that could affect the performance of this interface; that is, whether certain 
experimental variables are robust enough to be altered without any notable decrease in 
performance, or whether a delicate balance exists between these variables. Injection of 
POPC or EPC+ vesicle suspensions over a planar, silica surface resulted in altered 
deposition and antifouling effectiveness compared to the protein A/MPO surface, which 
we suspected to be attributed to differences in hydrophilicity and adsorbed surface features 
(e.g., from protein A and SAMs) (Figure 3.7). The effect of increasing the density of protein 
A deposited on the gold surface was investigated, which consisted of raising the incubation 
concentration from 10 µg mL-1 to 100 µg mL-1. MPO was retained for backfilling of 
interstitial space, and EPC+ injection and serum effects were analyzed by SPR. Effects of 
raising this concentration were deleterious, however, with a lower resonance angle shift 
(Δθ = 0.6 °) for the lipids, and increased nonspecific binding (Δθ = 0.4 °) from undiluted 
serum (Figure 3.8). Conversely, the effects of holding the 10 µg / mL of protein A constant 
while replacing MPO with other selected SAMs was tested. 3-mercaptopropionic acid 
(MPA) was selected for its similar length to MPO, though functionalized with a different 
end terminal (i.e., carboxylic acid) and charge, while 11-mercapto-1-undecanol (MUO) 
was selected for its identical end terminal functionalization (i.e., hydroxyl) and longer 
length. A protein A surface without any backfilling SAM was also included in this 
investigation. While the EPC+ lipids were successfully deposited on all surfaces at a similar 
level as protein A/MPO (Δθ ~ 0.8 °), nonspecific interactions with serum were notably 
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different (Figure 3.9). Both the protein A surface with no SAM and MPA-backfilled 
surfaces exhibited a higher level of nonspecific binding than protein A/MPO (Δθ = 0.1 °), 
though this was still minimal in comparison to a surface in which serum was introduced 
without EPC+ (Δθ = 0.73 °, Figure 3.2A). MUO faired the least successful of the SAMs 
studied, with an angular shift of ca. 0.25 ° after serum was introduced and rinsed with 
buffer. From these data, the packing density of protein A on the gold surface at 10 µg mL-
1 provides sufficient interstitial space for backfilling by an appropriate SAM. While MPO 
has proven to be the most efficient backfilling agent chosen, it can be inferred that the 
length of this SAM is the most critical parameter to balance against protein A surface 
chemistry, with the end terminal functionality playing a comparatively more minor role. 
 
 
Figure 3.7 Sensorgram depicting the extent of non-specific binding from human serum onto 
various lipids formed over silica coated gold chips.  POPC (blue), EPC (red), and POPG (green) 
were injected onto the surface (1) and incubated for 1 h, followed by the inject ion of undiluted 
human serum (2) for 30 min, and finally a PBS wash (3) was used to remove unbound serum 
components. 
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Figure 3.8 Sensorgram depicting the formation of EPC lipid vesicles over an increased 
concentration of protein A. Gold chips were coated with protein A at a concentration of either 10 
µg / mL (black) or 100 µg / mL (red), and 1 mM MPO.  A 1 mg / mL solution of EPC lipid vesicles 
were injected for 1 h (1), followed by undiluted human serum for 30 min (2), and a PBS wash (3) 
 
 
 
Figure 3.9 Sensorgram depicting the extent of non-specific binding from human serum components 
onto a protein A surface functionalized surface with varying spacers.  Gold chips were coated with 
10 µg / mL protein A only (green), protein A and 1 mM mercaptopropionic acid (blue), or protein 
A and 1 mM mercapto-un-decanol. EPC lipid vesicles were injected for 1 h (1), followed by 
undiluted human serum for 30 min (2), and a PBS wash (3). 
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3.3.4 Lipid-surface interactions and lateral mobility 
In light of this specific amalgam (i.e., protein A, MPO, and 100% EPC+) giving rise 
to such high antifouling efficacy, in contrast with the convention of using 
zwitterionic/neutral SAMs and brush networks for this purpose,36, 70 we sought a better 
understanding of how EPC+ assembles and interacts with the underlying protein A/MPO 
surface. Fluorescence recovery after photobleaching (FRAP) was employed to shed light 
on these interactions and glean information on the architecture of surface-adsorbed EPC+ 
structures. FRAP has been used to measure the lateral mobility of fluorescent molecules 
within liquids,71 hydrogels,71, 72 and lipid bilayers.41, 43 In principle, mobility kinetics may 
be assessed by bleaching a selected two-dimensional area under high laser intensity and 
monitoring the recovery of fluorescence within the bleached region as non-bleached 
molecules laterally diffuse and redistribute. Applied toward the study of lipid membranes 
supported by solid surfaces, only lipids within a contiguous lipid bilayer formed by fusion 
of adsorbed vesicles will exhibit measurable diffusivities (i.e., measure of the speed at 
which lipids are diffusing). If the diffusivity is low or the lipids are completely immobile, 
strong interactions with the surface or lack of vesicle fusion, both of which prevent long-
range mobility, could be inferred.41, 63 When EPC+ vesicles are applied to a glass support, 
a supported lipid bilayer is formed similar to POPC membranes on glass (Figure 3.10A).41, 
43 The lipids embedded within the EPC+ membrane are fluid and mobile, exhibiting a 
diffusivity (D) of 1.87 ± 0.12 μm2 s-1 and a mobile fraction (β) of 97 % (R2 = 0.97), with β 
serving as an indicator of the percentage of lipids that are freely diffusing. In contrast, EPC+ 
vesicles deposited over protein A/MPO behave far differently, exhibiting no redistribution 
 102 
of fluorescence within the region of interest after photobleaching (Figure 3.10A). 
Attempting to extract diffusivity and mobile fractions from this data result in near 
negligible values that do not fit the model for lateral lipid diffusion (R2 = 0.23), suggesting 
that these lipids, while appearing continuous and uniform, are tightly bound via strong 
electrostatic interactions to the underlying protein A/MPO surface. For reference, 50 % 
POPC/EPC+ vesicles exhibited a similar pattern in mobility, albeit with the FRAP results 
suggesting that the membrane is not as tightly bound to protein A/MPO with D = 0.42 ± 
0.35 μm2 s-1 and β = 44 % (R2 = 0.99) (Figure 3.11). The FRAP results confirm that EPC+ 
vesicles are tightly bound to the protein A/MPO surface after their introduction, and that 
the diffusional characteristics of embedded lipids are far different than conventional 
phosphocholine-based supported lipid bilayers on glass. Taken together with the 
antifouling characteristics unique to this identified set of constituents, the strong adsorption 
and self-assembled architecture of EPC+ on protein A/MPO appear to play critical roles for 
reduction of nonspecific binding. This architecture may consist of a tightly packed 
monolayer of adsorbed vesicles, or an immobile bilayer of EPC supported by protein 
A/MPO. As the vesicle diameter (ca. 100 nm), is below the diffraction limit of our 
microscope, neither could be confirmed by the fluorescence microscopy/FRAP studies. 
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Figure 3.10 Images depicting FRAP analysis of EPC+ lipids formed over a glass coverslip and a 
protein A/MPO coated coverslip. (A) Fluorescence micrographs of photobleaching and recovery. 
Scale bars represent 30 µm. (B-C) Corresponding recovery data for EPC+ over glass (B) and 
protein A/MPO surface (C). Error bars represent standard deviations from three replicate 
experiments. 
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Figure 3.11 Images depicting FRAP analysis of a 50% EPC / POPC lipid mixture formed over (A) 
a glass coverslip and (B) a protein A coated glass chip, and the corresponding recovery data (C) for 
the glass (I) and protein A surface (II). Standard deviations represent 3 replicate experiments, and 
scale bars represent 30 µm. 
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3.3.5 Characterization of Protein A surface for detection of antibodies in complex 
biofluids 
In order to confirm that this lipid membrane could be used in an immunosensing 
application and retain its high antifouling properties, a biosensor for IgG was constructed 
through incubation of a capture antibody, anti-IgG, over protein A/MPO prior to the 
introduction of IgG spiked serum. For this proof of concept experiment the selected capture 
antibody was raised against mouse, from which the target antigen was also procured, so 
that human antibodies present in serum or plasma would not be recognized. The binding 
of this capture antibody (100 µg / mL) to protein A was confirmed by SPR (Δθ = 0.17 °, 
Figure 3.12A), as was the deposition of EPC+ (Δθ = 0.55 °). The reduction of angular shift 
during EPC+ introduction compared to when no capture antibody is present (Δθ = 0.8 °, 
Figure 3.2C) is attributed to IgG being bound by protein A on the surface, thus reducing 
available deposition area. Blood plasma (Figure 3.12A) or serum (Figure 3.13) spiked with 
IgG (10 µg / mL) was then incubated over the surface for 1 h. While the majority of non-
specific components from plasma or serum can still be removed using a buffer rinse, no 
significant change in angular shift is observed between the samples with and without IgG. 
This is common in the detection of lowly abundant analytes in complex matrices, and the 
issue was overcome by simple addition of a detection antibody (i.e., anti-IgG) for indirect 
measurement.73, 74 Once introduced, angular shifts from the detection antibody were only 
observed for samples spiked with IgG (Δθ = 0.25 °), confirming specificity. This detection 
signal exhibits very little variation whether the matrix is plasma, serum, or PBS, and 
moreover, the EPC+ lipids appear to provide no deleterious effects on sensitivity, with a 
relative standard deviation (RSD) of only 9.7 % between all experimental conditions 
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(Figure 3.14). The use of protein A in place of a traditional coupling scheme (i.e., 
EDC/NHS coupling over a mercaptoundecanoic acid surface) also proves advantageous, 
with higher detection antibody signal observed when protein A is used (Figure 3.15), which 
is likely due to optimal capture antibody orientation. 
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Figure 3.12 Schematic and (A) sensorgram representing the detection of mouse IgG (red) in 
undiluted human plasma where the capture antibody is injected (1), followed by the EPC lipid 
vesicles (2), the plasma spiked with mouse IgG (3), and finally a detection antibody for 
enhancement (4). (B) Sensorgram representing the detection of CT (red) in undiluted human serum 
using the similar surface chemistry to the IgG, and the addition of serum spiked with CT (3), and 
finally a detection anti-CT for enhancement (4). (C) Sensorgram representing the detection of 
mouse IgG (red) in undiluted human serum where the capture antibody is injected was applied 
offline and the EPC lipid vesicles injected online (2), followed by the serum spiked with mouse 
IgG (3), a biotinylated detection antibody (4), streptavidin bridge (5) and biotin labelled gold 
nanoparticles (6) for enhancement. 
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Figure 3.13 Sensorgrams representing the detection of mouse IgG (red) in undiluted human serum 
where the capture antibody is injected (1), followed by the EPC lipid vesicles (2), the plasma spiked 
with mouse IgG (3), and finally a detection antibody for enhancement (4).  A 10 min PBS wash 
was included in between each step and a control sample was carried out by spiking the plasma with 
PBS only (black). 
 
 
 
Figure 3.14 Comparison of the antibody enhancement step for IgG detection in various matrices 
including plasma (blue), serum (red), and PBS (green), along with a no EPC analysis in PBS 
(purple).  
 109 
 
Figure 3.15 Comparison of the capture antibody attachment method, where anti-CT was 
conjugated to the surface via protein A (black) or via EDC/NHS coupling chemistry to 11-
mercaptoundecanoic acid (red).  Sensorgrams depict the addition of a secondary antibody after the 
detection of CT (1) and a PBS wash (2). 
 
 
3.3.6 Analysis of Cholera Toxin (CT) detection in undiluted serum 
To demonstrate the use of this interface for biosensing, specific recognition of 
cholera toxin (CT) in undiluted human serum was also performed. Though it targets the 
small intestine and is primarily diagnosed from stool, transport to the bloodstream though 
the jejunum has been documented,75 which may provide an additional vantage point in the 
characterization of disease progression.76 Once anti-CT (100 µg / mL) was immobilized on 
protein A/MPO, the antifouling capabilities of the EPC+ lipids are still observed, as 
demonstrated by the angular shift returning to baseline after the buffer rinse (Figure 3.12B). 
Similar to IgG, no direct measurement of CT (10 µg / mL) was noted, though specific 
binding of CT was readily confirmed using a detection antibody (i.e., anti-CT) 
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enhancement step, yielding an angular shift of 0.05 °. While this signal is lower than that 
for indirect IgG measurement, it is anticipated that a stringent screening for matching 
capture and detection antibody pairs will improve results.77 Nonetheless, this angular shift 
was proven to be concentration dependent, demonstrating the promise of this platform for 
targeted quantitation of biomarkers in crude samples (Figure 3.16) and confirming the 
results obtained for IgG measurement. 
While the above sensitivities should prove sufficient for many applications, there 
are a plethora of biomarkers that require more sensitive detection strategies for accurate 
clinical diagnoses and decisions to be made. Ultrasensitive SPR analysis can be achieved 
through electromagnetic coupling of metallic nanoparticles with the sensor chip, 
substantially lowering limits of detection.58, 73, 78 We therefore included additional 
enhancement steps to each of our model assays with the goal of targeted gold nanoparticle 
binding. Detection antibodies were conjugated with biotin, and introduced at a 
concentration of 1 µM. Using a streptavidin bridge (100 µg mL-1), the interaction of biotin-
labelled gold nanoparticles (bT20/AuNPs) was quantified and used to investigate the 
interaction specificity in the presence of the EPC+ barrier (Figure 3.12B). Although we do 
see some background binding from streptavidin, and hence, the bT20/AuNPs, we can still 
easily discriminate between when IgG (10 µg / mL) is present in serum (Δθ = 0.30 °) and 
when it is not (Δθ = 0.10 °). Similar results were obtained for nanoparticle-enhanced CT 
(0.05 µg mL-1) detection (Figure 3.17), where background signal (Δθ = 0.08 °) was lower 
than target-specific signal (Δθ = 0.21 °). Given that these bT20/AuNPs have been designed 
to carry a high density of negative charge through DNA spacers for maximum colloidal 
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stability,58 it is impressive that specific recognition is retained over EPC+ carrying a net 
positive charge, from which excessively high background would be expected. While the 
antifouling membrane formed over protein A/MPO is resistant to fouling from common 
blood derivatives, it could also be used in conjunction with other materials, organic or 
inorganic, for sensitive and specific recognition of clinically relevant targets. The limit of 
detection of cholera toxin achieved is 5 µg / mL with secondary antibody detection (Figure 
3.16) and 0.05 µg / mL with gold nanoparticle enhancement (Figure 3.17). The limit of 
detection is also reported in terms of number of molecules, which is summarized in Table 
3.1. 
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Figure 3.16 Calibration curve for detection of Cholera Toxin (CT) using an anti-CT enhancement 
step 
 
 
Figure 3.17 Sensorgram representing the detection of 0.05 µg / mL CT (red) in undiluted human 
serum where the capture anti-CT is injected offline and the EPC lipid vesicles injected online (2), 
followed by the serum spiked with CT (3), a biotinylated detection anti-CT (4), streptavidin bridge 
(5) and biotin labelled gold nanoparticles (6) for enhancement.  A 15-minute PBS wash was 
included in between each step and a control sample was carried out by spiking the serum with PBS 
only (black). 
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Table 3.2 Summary of SPR data for both IgG and CT in different test medium, detection 
mode (e.g., via detection antibody, AuNPs) and their angle shifts. 
 
To calculate concentration in number of molecules, the µg/mL was converted to Molar (M) 
then multiplied by injection volume (110µL) to obtain number of mol. The number of 
molecules were then determined by Avogadro's number. Molecular weight of IgG and CT 
is 150 kDa and 83 kDa, respectively.  
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3.3.7 Detection of CT with AuNPs amplification  
In addition to the results above, additional experiments and data were gathered 
during the course of CT analysis. The absorbance of synthesized 25 nm AuNPs and 
conjugated bT20/AuNPs were characterized with UV-Vis, not only to find the size but to 
confirm the conjugation result. By comparing the spectra of both AuNPs states, the 
bT20/AuNPs showed a red shift of the maximum peak indicates the increase of diameter in 
presence of biotin and the DNA spacer (Figure 3.18). The schematic and sensorgrams of 
CT detection with and without AuNPs enhancement are as showed in Figure 3.19 and 
Figure 3.20. 
 
 
Figure 3.18 SEM image of the 26 nm AuNPs used for the bioconjugation of biotin using DNA 
linkers.58 UV-Vis spectra showing the red-shift of the maximum peak indicates the increase of 
diameter in presence of biotin. 
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Figure 3.19 Schematic and (A) sensorgram representing the detection of cholera toxin (CT) (blue) 
in undiluted human serum where the capture antibody is injected (1), followed by the EPC lipid 
vesicles (2), the plasma spiked with CT (3), and finally a detection antibody (4)  
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Figure 3.20 Schematic and sensorgram representing the detection of cholera toxin (CT) (blue) in 
undiluted human serum with AuNPs amplification steps where the following injection was applied 
after step (3); biotinylated antibody (4), streptavidin bridge (5) and bT20/AuNPs (6) for 
enhancement 
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3.3.8 Comparing sensitivity of CT detection with and without AuNPs enhancement 
 The SPR measurements were repeated for different concentration of CT for at least 
three times per concentration, a calibration curve of the resonance change as the function 
of CT concentration was plotted (Figure 3.21), showing the linear range of the detection 
sensitivity. It is worth to mention that saturation (a plateau) occurred after 25 µg / ml and 
0.05 µg / ml of CT for the detection without and with AuNPs, respectively. Possible reason 
is because of the saturation at the analyte-antibody binding sites which makes further 
enhancement not significant. The calibration curves show that the linear range without 
AuNPs is 0 - 25 ug / ml, while after AuNPs enhancement a higher signal was obtained 
which enabled the lower detection range of 0 - 0.05 ug / ml. The angle shift (Dq) was 
calculated by subtracting the angle shift of the non-specific binding (control channel) from 
the shift of the specific binding (experiment channel). 
 
 
Figure 3.21 Calibration curves of the detection of CT (A) with and (B) without AuNPs 
enhancement. 
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3.3.9 Performance compared to the traditional self-assembled monolayer (SAM) 
We compared the detection system of using bilayer membranes to the traditional 
SAM. For this purpose, the golds chip was incubated with 11-mercapdoundecanoic acid 
(MUA) to form self-assembled monolayer with carboxyl group on the surface. Then, the 
anti-CT was immobilized onto the surface via EDC/NHS coupling chemistry to MUA. We 
showed that this surface chemistry can be successfully applied to undiluted human serum 
with minimal sacrifice in SPR signal when compared to buffered analysis. Using Protein 
A, lipid membrane and serum does not compromise detection of CT at same concentration 
25 µg/ml (∆θ=0.10+ 0.01o) (Figure 3.22). 
 
 
Figure 3.22 Sensorgram showing detection of CT on self-assembled monolayer in buffered 
analysis 
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3.3.10 Effect of serum incubation on protein A-lipid interface 
Our results showed that all non-specifically bound serum components were 
completely removed from the surface, as verified by the SPR signal when it returned to the 
level before serum injection after rinsing. However, it was unclear from this method, 
whether the EPC+ lipid bilayer was disrupted structurally by the serum. To address this 
question, we utilized fluorescence microscopy and FRAP analysis of the lipid on the 
Protein A/ MPO/ EPC+ in additional to serum incubation that mimics the SPR surface (a 
collaborative work with Daniel Stuart). First, the images verified that the fluorescence 
signal came from the fluorescent-tagged lipid, when no fluorescent was observed just on 
the protein A surface (Figure 3.23A). Although the fluorescent intensity of the protein A 
surface was lower on average without the serum (Figure 3.23B), we can still observe good 
coverage of fluorescent lipids and when compared against the control it clearly indicates 
that we have lipids remaining on the surface. The FRAP images in Figure 3.24A suggesting 
that there is a strong adsorption and self-assembled architecture of EPC+ on protein A/ 
MPO surface as no redistribution of fluorescence within the region of interest after 
photobleaching. The same finding was observed after incubation of serum, indicating the 
EPC+ structure remain strongly adsorbed on the protein A/ MPO surface even after rinsing 
(Figure 3.24B and Figure 3.25).  
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Figure 3.23 Images depicting fluorescence analysis of EPC+ lipids formed over a protein A/MPO 
coated gold slide. (A) Fluorescence micrographs of just the Protein A surface showing no 
fluorescence. Corresponding fluorescence micrographs for EPC+ on Protein A/ MPO surface (B) 
without and (C) with serum incubation 
 
 
 
Figure 3.24 Images depicting FRAP analysis of EPC+ lipids formed over a protein A/MPO coated 
gold slide. Fluorescence micrographs of photobleaching and recovery for the surface (A) Without 
serum. (B) With serum, from pre-bleach to t = 10s after bleaching 
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Figure 3.25 Corresponding recovery data for EPC+ over protein A/MPO surface, representative of 
both of the FRAP images for serum and without serum 
 
 
 Conclusion 
We have reported the use of charge-matched lipid membranes as an antifouling 
surface capable of carrying out analysis in undiluted human serum and plasma. By tailoring 
the charge of the lipid vesicles used, as well as selection of an appropriate backfilling SAM, 
the membrane successfully formed over a protein A surface, additionally allowing for 
orientation controlled immunosensing. We have shown that the addition of this membrane 
caused no reduction in SPR signal for bacterial toxin and antibody detection, and that 
analysis in complex matrices could be carried out with similar results to those seen for 
buffered samples. The sensitivity performance in CT detection was further improve by 
AuNPs amplification step. 
 122 
Moving forward and given the universal nature of protein A, this surface chemistry 
could potentially be used in a range of surface based biosensing platforms. Current 
techniques aside from SPR, including ELISA, fluorescent microarrays, and 
electrochemical based methods of analysis, which also suffer from non-ideal antibody 
orientation and ineffective surface blocking, could benefit from this novel surface 
chemistry, allowing for the sensing of clinically relevant targets within a range of complex 
biological matrices.  
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 SPR Study of Cancer Cell Toxicology Based on 
Morphological and Refractive Index Changes  
 
ABSTRACT 
Morphological changes of cancer cells are often used in the studies of efficiency of 
anticancer drugs.  Morphological cell analysis on cell size and shape distribution are 
typically performed by microscopic methods, which are time consuming and require 
skilled personnel. Recently, more advanced image processing and pattern recognition has 
enabled identification and quantitative analysis of the cells abnormality and classification 
in an automated way1. However, these methods usually involve multiple staining steps. In 
addition to computational complexity, the processes greatly compromise real-time 
applications of the system. Therefore, a non-invasive, real-time method allowing 
assessment of living cells’ reactions to a death inducer is very much needed. Here we have 
developed an SPR biosensor that measures the changes in cancer cells’ size and 
detachment, relating the cell confluency with the changes of the refractive index on the 
cell-substrate interface.  As a proof-of-concept, we chose HeLa cell and hydrogen peroxide 
(H2O2) induced apoptosis as the model system to study the morphological changes of the 
cell. The results show that the SPR response to the cell apoptosis agreed with the cellular 
morphology changes observed by microscopy.  Interestingly, we observed simultaneous 
apoptosis and necrosis when the concentration of H2O2 was high enough. The simultaneous 
occurrence was verified using a mathematical model, and other factors such as cell 
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thickness and intercellular refractive index were incorporated into the model, which helped 
resolve the disagreement between SPR signal and cell confluency at high H2O2 
concentrations.  Our results show the potential of SPR as a label free and real time 
monitoring method for morphology changes and surface detachment of cancer cells. This 
method can be fully expanded to other cell-based sensing applications.  
 
 Introduction 
SPR has been applied to the label-free, non-invasive and real-time monitoring of 
living cells’ conditions and functions for life science research and clinical diagnosis 
purposes.2 The cell-based SPR sensors are desirable due to intrinsic property of the sensors 
and many exciting potentials for exploration towards new biomedical fronts. Because SPR 
is a surface sensitive method, it is usually useful for the studies quantified by cell-substrate 
interaction of adhered cells. For example, SPR response to cell attaching and spreading 
processes, and cell attachment area as the result of the cells responses to biological and 
chemical stimuli.3-5 However, the actual mechanism of how the physical alterations of the 
cells affect influence SPR signal still remains elusive. There is limited literature on SPR 
detection of whole cells. One study relates the change of density on the sensor chip to the 
increase after the stimulation.6 SPR was also used to study morphological changes of cells 
in response to stimulation agents or cell death inducers.4, 7 
In more recent studies, the cell-based SPR began to include the influence of cell 
refractive index in explaining the SPR responses.  A study showed that the intercellular 
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cell components such as the membrane and nucleus possess a different refractive index.8 It 
was also found that cellular refractive index is distributed throughout the cell body and 
values vary at different stages of cell death.9 The influence of refractive index in cell bodies 
to SPR signal was demonstrated in a study where the SPR signal increases when the volume 
of the cell decreases as the cytoplasmic concentration increases leading to increase in the 
refractive index.10 The same conclusion was made by a study of exocytosis of cells , where 
the shift of resonance angle was observed due to elevated concentration of secretory 
vesicles close to the cell membrane.11 
In this study, we systematically investigated the SPR response to cell size, 
deformity and detachment, by relating SPR signal to the percentage of the surface of a 
substrate that is covered by adherent cells, known as cell confluency. Conventionally, the 
changes in cells after activation by molecular stimuli are often evaluated through changes 
in cellular morphology such as cell spreading, contraction, shrinkage and swelling, which 
are observed through a simple confocal and/or fluorescence microscopy, or through more 
sophisticated and quantitative microscopy techniques.12,13 However, microscopy 
techniques are limited by the resolution and are therefore unable to observe changes on the 
cell-substrate interface of adhered cells without being destructive to the cells. Therefore, a 
surface sensitive method, such as SPR, is a good alternative approach for quantifying cell 
confluency because it is sensitive enough to measure changes around the cell membrane 
adhered on the substrate. To further investigate this technique and to potentially improve 
the current status of cervical cancer therapeutic treatment, we choose to apply SPR analysis 
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to the morphological features of HeLa cells during cell death and the mechanism of cell 
death induced by hydrogen peroxide (H2O2). 
In 2018, a total of 570,000 cases and 311, 000 deaths were estimated for cervical 
cancer, making this disease the fourth most frequently diagnosed and leading cause of 
cancer death in women.14 Current treatments for cervical cancer include surgery, radiation 
and chemotherapy, and follow-ups after treatment are required to check for recurrences 
and to screen for possible complications.15 Most clinical trials  for patients with cervical 
cancer involve development of drugs that induce apoptosis, a type of cells death.16 Thus, 
recent advances in cervical cancer studies have mainly focused on identifying agents that 
can selectively induce cytotoxicity and stimulation of apoptosis caused by anticancer 
agents. In laboratory practices, cell-based assays are used as indicators of therapeutic 
efficiency, which is determined by measuring cell viability, cell proliferation, cytotoxicity, 
induction of apoptosis, and cell cycle arrest, and these methods are essential in early stages 
of anti-cancer drug development.17 The most commonly used assays include MTT assay,18 
TUNEL assay, 19 and LDH Cytotoxicity assay,20 which measure cell metabolism, DNA 
fragmentation and cell cytotoxicity, respectively. A study using SPR was reported to 
predict the efficacy of cancer drugs on human pancreatic cancer cells. The results showed 
a decrease of SPR signal as the percentage of cell viability increases.21 They hypothesized 
that the change of SPR signal was a result of decreased inner mitochondrial membrane 
potential. However, no relationships between the results and the biophysical cell-substrate 
interaction were determined. 
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The process of apoptosis has a unique biophysical cell-substrate interaction and 
therefore offers an alternative detection method other than the cell-based assays. Cells can 
undergo apoptosis through two apoptotic pathways; the death receptor pathway or 
mitochondrial pathway.22 This process of programmed cell death is characterized by 
distinct morphological characteristics such as cell shrinkage, cell rounding, membrane 
blebbing, chromatin condensation and nucleus fragmentation. With cell shrinkage, the cells 
are smaller in size and the apoptotic cell appear round.  For adhered cells, the size change 
is a direct measurement to surface area or confluency. Other than cells size, the shapes and 
thickness of apoptotic cells can be observed by light and electron microscopy23 and recently 
by atomic force microscopy (AFM).24 However these methods require pre-treatment and 
destructive to the cells. 
Our cell model system, HeLa, was derived from cervical cancer cells taken from a 
patient who died of cervical cancer. It was initially used for cancer research, but more 
discoveries on the cell have led to many important researches in biological science due to 
its immortality when given nutrients and a suitable environment.25 Hydrogen peroxide, as 
a reactive oxygen species (ROS), induces apoptosis in HeLa cell through the intrinsic 
mitochondrial pathway by several proposed mechanisms. Studies suggested apoptosis 
induced by H2O2 is mediated by decreased superoxide (O2-) concentration26 and by 
activation of p73 pro-apoptotic genes, which triggers apoptosis in response to DNA 
damaging agents.27  
The morphological analysis of HeLa cells under the growth phase and apoptosis 
have been examined by SEM, phase contrast, and fluorescence microscopy, showing that 
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control interphase HeLa cells have a polygonal shape while mitotic cells are spherical in 
shape and have a smooth surface (Figure 4.1).28  
 
 
Figure 4.1 Different morphologies of HeLa cells observed either by SEM (A, A′), phase contrast 
microscopy (B, B′ ); or fluorescence microscopy (C). Reprinted from Ref. 27, Copyright 2005, with 
permission from Springer 
 
 
In contrast, apoptotic HeLa cells exhibited rounding, shrinkage, and severe 
blebbing of the plasma membrane.28 As shown in Figure 4.2, early apoptotic cells lose 
plasma membrane connection with neighbor cells before the detaching process, and 
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eventually, detached cells appear to float in the culture medium. Apoptotic HeLa cells also 
demonstrated a reduction in cell density and rounded shrunken cells.29  
 
 
 
Figure 4.2 Top: SEM images of apoptotic HeLa cells. Edited from Ref. 27, Copyright 2005, with 
permission from Springer (top) and Ref 28 (bottom)   
 
The ability of SPR to detect and quantify morphological characteristic of cells is very 
useful for diagnosing cancer and in studying the efficiency of anticancer drugs. For the 
diagnosis, cancer cells can be detected and classified by the specific features including the 
shape and size, and the distribution of the cells.30 This is useful when comparing the 
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normal, pre-cancer and malignant cells, as demonstrated in studies of breast cancer31, 32 and 
cervical cancer33. Moreover, SPR does not require the cells to be fixed to preserve the cells, 
compare to other microscopic methods. However, the physical features more related to 
SPR capability are the cell-cell and cell-substrate interactions. For example, cancer cells 
often become disordered, and less adherent to the other cells and to the extracellular matrix, 
34 which cause the changes in confluency and optical properties on the interface, both are 
measurable by SPR. 
In this work, the change of SPR response towards HeLa cell morphological changes 
on the sensor chips was studied (Figure 4.3). Experimentally, HeLa cells were cultured on 
SPR chips until 80% to 100% confluent monolayer was achieved. SPR measurements were 
then carried out with injection of different concentrations of H2O2 where the signals 
changes were observed until stabilized. Another set of chips were prepared in a six wells 
culture plate where the same H2O2 treatments were performed and the cells images were 
taken using a microscope. The SPR sensorgram results were then compared with cell 
confluency data after the images were processed with Image J. 
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Figure 4.3 SPR measurement to measure resonance angle towards cell morphological changes on 
sensor chip 
 
 Experiment Section 
4.2.1 Materials and Solutions 
The human cervical cancer HeLa cell line was purchased from American Type 
Culture Collection (ATCC) and cryopreserved in a liquid nitrogen storage until use. The 
cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) (1X) supplemented 
with 10% fetal bovine serum (FBS) from Gibco. Cells were cultured at 37oC, 5% CO2 in a 
humidified incubator. Cells were harvested every 2 days by standard trypsinization (0.05% 
Trypsin-EDTA (1X) from Gibco) to suspend the cells. To prepare the running buffer for 
SPR, the HEPES-buffered salt solution (HBSS) was chosen, as this buffer is recommended 
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to keep the cells viable for longer time at room temperature without CO2 supply.  The 
buffer contains 10 mM HEPES, 150 mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 2 mM CaCl2 
and 10 mM D-glucose, pH 7.4 adjusted with NaOH 11. The buffer was filtered, degassed 
and autoclaved before use. For cell culture and SPR, the sanitization was done using 70% 
ethanol spray. 
4.2.2 Apparatus 
For cell culture, a Class II A/B3 biological safety cabinet, Fisher Scientific 
ISOTEMP 205 water bath, Pelton & Crane Validator 8 autoclave, CF-80-1 electronic 
centrifuge, Fisher Scientific CO2 incubator and Kenmore lab refrigerator were used. 
Microscopic imaging was done with Omano microscope with AmScope digital camera. 
The refractive index of various liquid solutions was measured with American Optical 
ABBE refractometer. SPR data was measured with NanoSPR 3 (Addison, IL) with 650 nm 
GaAs semiconductor laser light source and Orion Sage syringe pump. Nanopure water (> 
18 MΩ.com), purified through a Barnstead E-Pure filtration system (Thermo Scientific, 
Rockford, IL) was used for all reagent preparations and rinsing.  
4.2.3 HeLa cells reactivation and seeding 
A vial of cryopreserved cells from liquid nitrogen storage was thawed in a 37oC 
water bath, just until ice is no longer visible. The entire content was transferred into a 15-
mL conical centrifuge tube with 3 mL growth medium (DMEM supplemented with 10% 
FBS). Then, 1 mL of the medium was added into the cell vial, rinsed and added into the 
centrifuge tube. This step was repeated several times to make sure all content from the cell 
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vial was transferred into the centrifuge tube. Once transferred, the cells were centrifuged 
at 4000 rpm for 10 min. After that, remove supernatant was carefully removed from the 
centrifuge and disposed accordingly. The cell pellets were resuspended in a culture flask 
filled with 7 mL growth medium, added into culture flask (Figure 4.4) and the suspension 
was checked under microscope to ensure the cells were uniformly distributed. Finally, the 
cells were kept in a 37oC, 5% CO2 humidified incubator. 
4.2.4 Culturing of HeLa cells 
HeLa cells, pre-incubated in a culture dish, were harvested at about 80% 
confluence. A buffer exchange was performed by first discarding the growth medium from 
the culture flask. Cells were detached from the culture flask by a standard trypsinization 
protocol. For this purpose, 2 ml of 0.05% trypsin was added into the culture flask and 
placed in incubator to allow the trypsin to work. The flask was inspected microscopically 
every minute until the cell is slightly detached from the wall and appeared rounded. Once 
the cells appeared detached, the trypsin was removed from the flask. Then, the flask was 
rinsed by pipetting 5 ml medium over the cell layer surface with several times to ensure 
sure the cells is transferred and dispersed into the solution. Then, 2 ml of the cell suspension 
was transferred into a new culture flask and then resuspended in a 5 ml of fresh medium. 
The cells were kept in incubator and subcultures of confluent cells were performed every 
1-2 days. 
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4.2.5 Culturing of HeLa cells on SPR chips 
Gold chips from glass slides were fabricated with layers of e-beam deposited 4 nm 
Chromium and 50 nm gold, using the cleanroom facility at the UCR. Prior to use, the chips 
were rinsed with the Nanopure water, pure ethanol and air dried.  gold chips with DIW, 
pure ethanol and air dry. Next, the chips were sterilized by UV radiation overnight. For 
cell culture, the chips were immersed in 8 ml of culture medium using 6 well cell culture 
plate (Figure 4.4). For cell suspension preparation, HeLa cells were removed from culture 
flasks by trypsinization, suspended in 8 mL of culture medium. A 2 mL of this cell 
suspension was transferred into a new culture flask, followed by adding 5 mL of culture 
medium. One mL of the suspension and 3 mL of culture medium were added into each 
well. The wells content was inspected under microscope for uniform distribution of cells. 
The chips were kept in the incubator for 1-2 days until their surfaces were covered with 
~80-100% layer of cells, prior to use for SPR. 
  
Figure 4.4 Culture flask and 6 well culture plate for cell culture 
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4.2.6 SPR measurements 
The measurements of SPR signal response to HeLa cells death were performed on 
the NanoSPR instrument equipped with a PlasmonSerial software that provides the 
reflectivity curve and sensorgrams of the real-time minimum angle. The running buffer in 
which the chips were immersed when are not exposed to H2O2 solution, in this study being 
the HBSS, also functioned to rinse the solution off the surface before the next solution is 
introduced. The syringe pump controlled the buffer flow speed and was used to set the 
pump on pause for incubation purpose.  All SPR measurements were done at room 
temperature. Prior to measurements, the microfluidic systems consist of the chambers and 
inlet/outlet tubing, the injection ports and the device accessories were sterilized by flowing 
70% (v/v) ethanol for 30 min and then rinsed with HBSS. The cell coated chips were 
transferred immediately from the incubator to the SPR using a pre-sterilized tweezers. The 
back side of the chips were cleaned with 70% ethanol and water, followed by applying a 
thin layer of refractive index matching liquid (n = 1.517, Cargille Laboratories New 
Jersey), before the chips were placed on top of a BK7 prism. The flow cell consists of two 
30 µL flow channels (Figure 4.5) was attached afterwards, and the buffer flow were run 
for 30 min to obtain stable baseline, before injection of H2O2 at a flow rate of 5.0 mL/h. 
The signal was monitored until no further increase or decrease for at least 40 min before 
the flow pump was turned on for rinsing. After the measurement was completed, the outlet 
was disposed in a biological container and the instrument parts were cleaned with 70% 
ethanol.  
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Figure 4.5. SPR flow cell in actual image and schematic drawing showing the bottom structure 
 
4.2.7 Microscope examination of the cell covered SPR chips  
For relating SPR response to cell confluency, the microscope imaging was 
performed at the conditions and procedure replicating SPR experiments. All cells covered 
chips were examined for cell viability and confluency using microscopy prior to SPR 
measurement and when the cells were exposed to different concentrations of H2O2. The 
chips were removed from incubator and were placed in a 6 well plate staged on the 
microscope platform. A 5 mL of HBSS buffer was added into the wells and was left for 30 
min. The cell images were taken at specific time intervals using the digital microscope 
camera before and after exposure to H2O2 at 25x magnification. To ensure accuracy, the 
images were taken at the same location on the chips.  
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4.2.8 Cell confluency measurement  
The cell coverage on the chip was measured by Image-J. A calibration was 
performed using a stage micrometer prior to measurements. To quantify the fraction of 
covered areas, the cells boundaries were traced manually using the freehand selection tool 
to enable the image threshold function. Then, the particle analysis tool was used to 
calculate the percentage of covered area, which also represents the cell confluency. This 
method can also be used to determine cell number, cell density and cell shapes, which are 
another useful parameter in call-based assay and in estimation of adherent cell culture 
characteristics. 
 
 Results and Discussions 
4.3.1 Characterization of the SPR system for monitoring living cells  
To show that our SPR system can be applied to monitoring cell-surface interactions, 
we first investigated the SPR response of HeLa cells detachment form the gold surface 
using trypsin. In this preliminary study, 10 mM PBS (137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4 and 1.8 mM KH2PO4) was used as the running buffer. From the sensorgram 
(Figure 4.6), the experiment channel where 0.05% trypsin (in PBS) was injected showed 
the signal rapidly decreases after 4 min into incubation. For comparison purposes, a time-
lapse microscopic image was also captured on a separate setup that represents the timing 
procedure conducted on SPR. From the inserted image, at 4 min exposure to trypsin, the 
cell confluency decreases because the cells become smaller in size, as trypsinization 
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induces rounding up of HeLa cells that leads to detachment from the gold surface. 35, 36 The 
signal continued to decrease at a fast rate (Dq = 1.0o) and then plateaued after the cells 
completely detached from the surface during the rinsing step, , as shown by the inserted 
image. In comparison, the control channel where PBS was injected instead of trypsin, the 
rate of decrease was smaller, even after rinsing; the cells maintained their shape and the 
signal decrease was caused by the change of refractive index from culture medium to PBS 
(Figure 4.7). After 20 min incubation with trypsin, the channels were rinsed with PBS. This 
result demonstrates that our SPR system is sensitive to changes in cell confluency and 
attachment, and the observed trends are in agreement with the results from the literature, 
where it was also demonstrated that the effective refractive index decrease as cells detach 
from their initial surface.3, 11 
 
 146 
 
Figure 4.6 HeLa cell detachment progress monitored using SPR by the injection of Trypsin. After 
30 min baseline, the culture medium was injected and incubated for 2.5 hrs. The 5 min wash was 
followed by Trypsin incubation for 20 min (red channel). After 4 min the cells started to shrink. 
Final wash with PBS removed the cells from the surface. 
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Figure 4.7. Analysis of sensor chip after SPR measurement showing the cells were removed from 
surface treated with Trypsin (top channel). The non-treated cells remained on the surface (bottom 
channel) 
 
 
4.3.2 Microscopic images of cell morphology changes after exposure to H2O2 
To quantify the cell confluency and to compare the microscopic images with our 
SPR signal, time-lapse imaging was collected for 0.1 M, 0.5 M, 1.0 M, 2.5 M and 5.0 M 
of H2O2 (Figure 4.8). The images show a decrease in the cell size and an increase in the 
amount of the intercellular space, due to apoptosis. The images were processed by Image 
J to calculate the total cell attachment area. For example, the cell confluencies extracted 
from the images of 1.0 M H2O2 were 82%, 60%, 50%, 45% and 40%, at 0 min, 30 min, 60 
min, 90 min and 120 min, respectively (Figure 4.9). It can be seen that the confluency 
decreases with incubation time at the 1.0 M concentration. 
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Figure 4.8 Time-lapse microscopic imaging (25x) of HeLa cells after exposure to 2.5 M H2O2. 
From the images, our HeLa cells grown to 30 – 40 µm in length at confluent. 
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Figure 4.9. Images of HeLa cell after exposure to 1.0 M Hydrogen Peroxide (H2O2) and 
percentage confluency determination (A) Microscopy 25X and (B) Threshold analysis by Image J, 
the white spots represent the cells. 0 min (85%), 30 min (60%), 60 min (50%), 90 min (45%) and 
120 min (40%) 
 
4.3.3 SPR monitoring of cell morphological changes after exposure to H2O2 
The cell morphology changes especially the reduced size due to shrinkage is a 
distinguishing feature of HeLa cell death induced by apoptosis.  Therefore, cell confluency 
measurement could be used to evaluate the relationship between SPR response and HeLa 
cell toxicity. For the SPR measurements, one channel was dedicated as the experiment 
channel where the H2O2 was injected, which the other channel was the negative control 
channel that is without H2O2. The negative control is needed to confirm that the observed 
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changes were cause by direct stimulation by H2O2 and not by other factors such as 
temperature or the buffer flow shear.  As shown on Figure 4.10 (top), after 50 min baseline, 
1 M of H2O2 was injected into the experiment channel while HBSS was injected into the 
control channel. The change in SPR response after exposure to H2O2 was then monitored 
by SPR until 120 min after injection, when the flow pump was turned on for the rinsing 
step. From the sensorgram, a decrease in SPR response (Dq = 0.3o) was observed for the 
H2O2 channel while the control channel remained steady.  
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Figure 4.10. SPR sensorgram showing SPR response after injection of 1 M H2O2 (top) and 
microscopy images taken at corresponding times showing the progression of cell size after the 
stimulation (bottom) 
Throughout the experiments, another chip with confluent HeLa cells was placed on 
a petri dish on the microscope platform. A picture was taken before 1 M of H2O2 was 
injected into the petri dish. Microscopic images were taken every 30 min and rinsed at the 
end point, for the 1 M concentration, as in Figure 4.10 (bottom). The images were analyzed 
using Image J to calculate confluency and were used for the next analysis. However, even 
without additional analysis the decreased confluency over time can be visually observed. 
Next, the experiments were repeated for different concentrations of H2O2, the results were 
summarized in the same plot (Figure 4.11). From the results, 0.1 M of H2O2 has the least 
effect on HeLa apoptosis as the signal is nearly unchanged after injection. For other 
concentrations, a significant decrease in SPR angle shift was observed; 0.2o, 0.3o, 0.5o and 
0.9o for 0.5 M, 1.0 M, 2.5 M and 0.5M, respectively. Higher concentration of H2O2, starting 
from 2.5 M caused formation of air bubbles inside the channel, which were removed by 
tapping the flow chamber, as depicted on the plot by a sharp drop at 20 min and 30 min for 
2.5 M and 5.0 M, respectively. At the 5.0 M concentration, the SPR response decreased at 
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a fast rate and achieved a steady signal after 25 min. After 60 min, the flow pump was 
turned on causing drastic signal drop when all cells were detached from the surface. These 
results confirm that higher concentration of H2O2 lead to a stronger toxicity effect to HeLa 
cells and that the system is sensitive to the concentrations. 
Figure 4.11. SPR sensorgram showing signal change when HeLa cells were exposed to different 
concentration of H2O2 
 
4.3.4 Relationship between SPR signal and cell confluency  
To evaluate the correlation between SPR response with the changes in cell 
confluency, the data of each H2O2 concentration were plotted on a same graph (Figure 
4.12). The results show that a decrease in cell confluency leads to a decrease in SPR angle 
shift, Dq. The magnitude of the changes increase as the concentration of H2O2 increases, 
as expected. We also observed the slope of the line, representing the rate of the changes, 
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were higher at the beginning of the measurements for all concentrations. The shape of the 
curves for SPR response and cell confluency closely match at lower concentrations, which 
means that the correlation becomes weaker at higher concentrations. A possible reason 
could be SPR is a more sensitive method than microscopy, taking into consideration the 
change of the effective refractive index on the substrate surface.  
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Figure 4.12 Correlation between SPR response (blue line) and cell confluency (red line) 
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The same observation was reported in a study of cell confluency during HeLa cell 
attachment and spreading,3 where the SPR results were much lower than cell confluency 
by microscopic imaging, although the overall trends were similar. They postulated it was 
because cells attached to the substrate with gaps in the cell-substrate contact, therefore the 
effective attachment area detected by SPR was less than the imaging attachment contour 
area. Nevertheless, our SPR results shows very good correlation with cell confluency at 
very low concentrations (0.1 M to 1.0 M), while the change of cell confluency was not as 
drastic at higher concentrations. 
 
4.3.5 Explaining the abnormal behavior at high concentration of H2O2 
From the results, HeLa cells exposed to 5.0 M H2O2 exhibits different behavior 
between SPR signal and cell confluency compared to the lower concentrations. At 5 min 
exposure time, the SPR signal keep decreasing while the confluency increases then 
decreases again at 30 min. The microscopy images of HeLa cells induced with 5.0 M H2O2 
(Figure 4.13, top) where the confluency data extracted using Image J (Figure 4.13, bottom), 
showed the confluency decreased from 90% to 34% in 5 min, then increased and stabilized 
around 43% before decreasing to 37%. This indicated cell shrinkage occurred in the first 5 
min before the cells underwent swelling that increases confluency and then reducing in size 
again. This trend can be explained by cell death mechanism induced by H2O2, according 
to literatures that high concentration of H2O2 induces necrosis, whereas low concentration 
induces apoptosis.28, 37, 38 For HeLa cells, it was reported that  0.1 M of H2O2 induced 
 156 
necrosis28 and 125 µM induced apoptosis.27 For our study, cell death by necrosis was 
achieved at 5.0 M and we did not have data to show whether necrosis happened at lower 
concentrations than 5.0 M. Necrosis, refers to the degradative processes that occur after 
cell death and does not follow the apoptotic signal transduction pathway.22  Necrosis 
usually happens following apoptosis but can also occur simultaneously depending on 
factors such as the intensity an duration of the stimulus.39 Necrosis is distinguished from 
apoptosis by the different in morphological changes, as observed by cell swelling, loss of 
membrane integrity and possible release of the cytoplasmic contents into the 
surrounding.40, 41 Our results indicate that apoptotic cells during 2 min exposure to H2O2 
exhibited cell rounding, shrinkage and detaching. In 4 min, the cell membrane started to 
disintegrate, and the cell inner body began ruptured, indicating early necrosis, while some 
cells remain apoptotic.  After 6 min we observed cell swelling and the number of necrotic 
cells increased (Figure 4.14).  
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Figure 4.13. HeLa cells exposed to 5.0 M H2O2 over time. The upper images are the original images 
and the lower show processed threshold images by Image J with the respective percentage 
confluency 
 
 
 
Figure 4.14. Analysis of HeLa cells apoptotic and necrotic features induced by 5.0 M H2O2 
 
 
This observation was in agreement with results reported in a study that distinguished 
cell death induces by apoptotic and necrotic treatment of HeLa cells.28 In the study, necrotic 
cells were characterized by loss of membrane integrity, as well as cytoplasmic damage 
during early necrosis, followed by uniform condensation and fragmentation of the 
2 min 4 min 6 min 
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chromatin (Figure 4.15). In the late stage of necrosis, cell flattening occurred and 
eventually the cell body completely detached while some debris remained on the surface. 
The complete detachment of the cell bodies may be the reason for decreased cell size at the 
end of necrosis, leading to decreased confluency. Even though we were able to validate the 
trend in cell confluency induced by 5.0 M H2O2, the reason why SPR does not respond 
with the same trend remained unexplained. Clearly, the combination of different 
morphological features of apoptosis and necrosis are affecting SPR response, which 
provoked us to reexamine the biophysical changes on the cell-substrate interface, as these 
contribute more toward changes of SPR signal than the cell morphology. 
 
Figure 4.15. Microphotographs of HeLa cells showing that characterize the cell death in early (A”, 
B”) and late (C”) necrosis. Edited from Ref. 27, Copyright 2005, with permission from Springer 
 
 
4.3.6 Mathematical modelling of SPR response 
A mathematical relationship between the SPR signal and the adsorbed film 
thickness and coverage was previously established based on the effective refractive index 
model.42 This model allows quantitative analysis to predict the response of an SPR sensor 
when molecular or adsorbate (for example thiolate, protein and cell monolayer) binds on 
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an SPR surface and the adsorbate has a different refractive index from the bulk solution. 
The theoretical description for the SPR signal response to a bulk solution and a uniform 
layer of adsorbate, is shown in  Figure 4.16, where R is the SPR response as the shift in 
angle (Dq), Dh is the change in the refractive index, m is the slope of the calibration curve, 
which is also the sensitivity factor for SPR, hs and ha is the refractive index for the bulk 
solution and the film layer,  d		is	the	thickness	of	film	and	𝑙d		is the characteristic decay 
length, which is 20 to 50% of the wavelength of light source used in SPR. The slope of the 
calibration curve was obtained by sequentially injecting 0.5 M, 1.0 M, 1.5 M, 2.5 M, 3.0 
M and 5.0 M NaCl solutions, and each injection was separated by a buffer wash. A graph 
of SPR response vs. bulk refractive index of the solutions was plotted  to determine the 
dynamic range of the SPR system, allowing the m value to be obtained by fitting into the 
model equation. It can be seen from Equation 2 that the SPR response is determined by the 
refractive index of HeLa cell intracellular fluid and the bulk solution, and the thickness of 
the cell layer.  
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(a)                                                                      (b) 
 𝑅 = 𝑚	Dh = 𝑚 QhRS<TU − hS<SWSTUXEqn. 1        𝑅 = 𝑚(𝜂T − 𝜂[)[1 − 𝑒𝑥𝑝(−2𝑑/𝑙e)]       Eqn. 2 
Figure 4.16. Schematic diagrams and corresponding equation of the working interface of a thin 
metal film in contact with (a) bulk solution s and (b) a bilayer structure consisting of a uniform 
layer adsorbate a and bulk solution s (edited from 42) 
 
The accuracy and stability of our SPR measurements were verified by comparing 
the SPR angle measured for different buffers with the calculated values from the equation 
obtained from the calibration curve. The data were compiled in Table 4.1, showing good 
agreement between SPR angles obtained from experimental and calculated data, for 
different types of buffer solutions.  
Table 4.1. Comparison of experimental and calculated SPR angle shift for different buffers 
Bulk solution RI θcalculated θexperimental 
DIW 1.334 62.4o 62.3o 
PBS 1.338 62.5o 62.6o 
HBSS 1.338 62.5 o 62.8o 
5.0 M H2O2 1.345 62.7 o 63.0o 
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4.3.7 The SPR response to a single adlayer of uniform thickness 
For such structures as shown in Figure 4.16b, a thin film of uniform thickness d and 
refractive index of ha is adsorbed to the metal surface of SPR chip, with a bulk liquid 
solution with refractive index hs is above the layer, and the SPR response in angle shift 
(Dq) can be calculated using Equation 2. This equation was simplified from the estimation 
that the effective refractive index of the bilayer, heff, is the properly weighted average of 
ha plus hs. Other assumptions made in this model are that the evanescent electromagnetic 
field decays exponentially into this medium with a characteristic decay length, 𝑙d, ~25-50% 
of the wavelength of the incident light, and the intensity of light is the field strength 
squared, so it decays with height z  above the metal surface as [exp(-z/	𝑙d)].2 The above 
assumption is valid for an SPR response that is linearly proportional to the change of 
refractive index over the range ha plus hs. For a nonlinear response, this relation is no longer 
valid and must be replaced with a different equation. 
We then plot the curve of SPR response in Dq as a function of adlayer thickness (of 
a confluent HeLa cells on a 50 nm gold chip in HBSS buffer) as predicted in Equation 2, 
for a particular value of m, ha , hs and 𝑙d (Figure 4.17a) and plot the curve in SPR angle q 
taking 62.8o as initial angle when there is no cell layer on the surface (Figure 4.17b). From 
these plots, we can estimate the thickness of the cell layer from the measured and calculated 
SPR response. Based on our data, the measurable thickness of HeLa cells is less than 300 
nm. In addition, we can see that after 400 nm the SPR response is no longer sensitive to 
the changes of the cell-substrate interface. 
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a                                                                          b 
  
c                                                                         d 
 
 
 
 
 
 
4.3.8 Corrections for SPR response to include nonuniform coverage 
Other than the calculation for uniform adlayer, our model also considers 
nonuniform coverage like the structure in Figure 4.18, where the adsorbate covers a 
fraction (f) of the metal surface with thickness of d. In this case, the SPR response is just f 
Figure 4.17. Calculated SPR response to thickness d,  in angle shift (a) and in angle (b), for a bilayer 
of HeLa cells on gold chip in HBSS solution, as represented on Figure 18b, where  ha = 1.392,        
hs = 1.338, λ= 650 nm, 𝑙d  = 325 nm (50% of λ). The curve fitting is calculated using Equation 2 
with m =33o per RIU as obtained from the linear calibration plot (c) using a bulk NaCl solution 
from h = 1.336 to h = 1.381 (0.5 M to 5.0 M). (d) Refractive Index of H2O2 (hs) at different 
concentrations used in the calculations 
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times the response when f = 1, which is the response for uniform coverage calculated using 
Equation 2. We then used the correlation to calculate the SPR response as a function of 
percentage cell confluency (f). This assumption is valid for when the thickness, d, is less 
or about the same as ld, which is true in our case. For a very small thickness, the response 
of nonuniform structure would be the same as uniform structure, while for a very large 
thickness it would give a complex SPR with a double minimum reflectivity curve, where 
any material further away from the metal surface does not contribute strongly to the SPR 
response.  
 
 Rnon-uniform = f x Runiform   Eqn. 3 
 
Figure 4.18. Schematic diagram of a bilayer structure with a nonuniform coverage, adapted from 
ref 42 
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4.3.9 Comparison between measured and calculated SPR response to cell confluency  
For this purpose, we calculated the SPR response over time for each H2O2 
concentration, based on the confluency data plotted in Figure 4.12, and the combined 
sensorgrams are shown in Figure 4.19. The thickness of the uniform cell layer was 
determined from the SPR angle at baseline before H2O2 was injected and by using the 
angle-thickness data in Figure 4.17C. After the thickness was obtained, we were able to 
calculate the SPR response by Equation 2, which is the Dq when f = 1. The data of Rnon-
uniform are the response of Runiform times the percentage confluency, as indicated in Equation 
3. Because the calculations are highly dependent on percentage confluency, the trend 
observed for the calculated response is the same as the confluency data, where the 
correlations are better at lower concentrations. An abnormal behavior was observed for 5.0 
M H2O2, where the calculated response does not follow the experimental data after 5 min 
of exposure, with the signal increasing instead of decreasing.  
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Figure 4.19 SPR experiment (black) and calculated (red). For the calculated SPR response, the 
refractive index of H2O2 solution used as following hs of 1.3365, 1.3377, 1.3389, 1.3419, and 
1.3476, for 0.1 M, 0.5 M, 1.0 M, 2.5 M and 5.0 M, respectively. 
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As discussed in Section 4.3.5, different morphological events occurred at high 
concentration of H2O2 caused by simultaneous apoptosis and necrosis. Necrotic cells are 
distinguished from apoptotic cells by the amount of cell swelling, as observed by the 
increased percentage of confluency after a 5 min exposure time. We investigated this 
further by visually differentiating necrotic from apoptotic cells using the microscopic 
images, and re-calculated percent confluency contributed by each condition. The results 
are shown in Figure 4.20, where we compared confluency of all the cells with confluency 
from apoptotic (A) and necrotic (N) cells. We observed the cells were all necrotic at 20 
min (41% confluency) and possible apoptotic blebs detached from the surface and float 
into the solution, causing reduced confluency to 36% at 40 min.  
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Figure 4.20 Cell confluency according to apoptotic and necrotic HeLa cells exposed to 5.0 M 
H2O2  
 
In a study where HeLa cell morphological changes during apoptosis were observed 
using AFM,24 the images provided a better understanding on the size and thickness of the 
cells at the death stages, which support our observations. During the cell death progression 
as reported in the paper, the cells initially shrank, and the thickness increased. This explains 
why confluency decreased initially, before increasing, as the membranes start to become 
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damaged followed by swelling. At this stage, the thickness keeps decreasing. As the blebs 
start detaching, the cells shrink again causing less confluency while the thickness increases. 
Evidently, there is a combination of size and thickness changes that were not able to be 
observed under the microscope but were detected by SPR due to the sensitivity of this 
method to minute changes on the surface. In addition, we found that the refractive index 
inside the cell body changes at different stages of apoptosis, and this change itself is a result 
of changes to the intracellular biochemical components and volume.9 Therefore, in addition 
to cell thickness, the refractive index is also a variable that changes during cell death that 
directly change SPR response, as indicated in Equation 2. Furthermore, the derivation to 
achieve Equation 2 can be done in a more complex way for adlayer of cells, by factoring 
various cell shapes43 in the formulation of the decay length, ld, instead of assuming the 
value to be 20% to 50% of the wavelength of the light source.  
Although it is a challenge to establish a comprehensive theoretical model 
interpreting all SPR responses to cell morphological changes, further development is not 
impossible. A few studies have addressed quantitative issues to study SPR response in cell-
based applications.43-45 For example, a quantitative SPR was applied in a study of cells 
attachment, spreading and proliferation phase, by modifying the effective refractive index 
to include cell density and spreading area.3 However, the experimental SPR response 
agreed well with the calculated response only in the spreading phase, while the magnitude 
is largely different in the proliferation phase. Therefore, a revised mathematical model with 
a better fit between experimental and calculated SPR responses would be desired.    
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 Conclusions  
In conclusion, we have validated the SPR study on the toxicity of cancerous HeLa 
cell induced by H2O2 by monitoring the changes in SPR signal in response to the change 
in cell confluency and cell detachment caused by the cell death mechanisms. Several 
important findings were achieved. First, when compared with the microscopic images, we 
found that SPR signal decreases with decreasing cell confluency after the treatment with 
H2O2.  Second, the correlation was valid only at lower concentrations since 5.0 M 
concentration of H2O2 is not proportional to cell confluency because it induces apoptosis 
and necrosis simultaneously. Quantitative analysis of SPR signal in response to cell 
confluency was carried out to investigate other factors affecting the shift in SPR signal. 
The results verified the complexity of cell morphology that cannot be observed just by 
microscopy technique and that SPR is more sensitive to the changes on the cell-substrate 
interface. Although the mathematical model equation works in lower H2O2 concentrations, 
more complex derivations and simulation to solve complex mathematical models are 
needed. This is because cell activities change the morphology in many ways, including 
thickness of the cell layer, shapes, and refractive index in the cell bodies. Therefore, for 
more accurate interpretation, the mathematical equation has to include the non-uniform 
thicknesses, various shapes, and refractive indexes of cell intracellular.  Although SPR will 
not replace conventional cell-based assay to monitor cell responses to biological and 
chemical stimuli, or cell death inducers, it provides simple screening tools and quantifiable 
measurements comparable to other methods. This method can find broad applications for 
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other living cells studies in medical fields, especially in anticancer drug development and 
clinical diagnosis. 
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 Conclusion 
Biomedical is a broad area of science that looks for ways to prevent and treat 
diseases that cause illness and death in human. The diagnostic process through laboratory 
testing has been said to be 60% to 70% of critical decisions in diagnosis and treatment of 
diseases, and aids in the effective Diseases Management (DM).1 The diagnostic tests are 
categorized into general chemistry, immunochemistry, hematology/cytology and 
microbiology that measures compounds in the body, match antibody-antigen response, 
blood and cells, and detect disease-causing pathogens. However, despite the advances in 
biomedical analysis, there is still a need to improve the current diagnostic landscape 
especially for infectious diseases that would benefit from new technologies that can 
identify a specific pathogen in a simple and rapid manners.2 One of the most promising 
approaches for making early disease diagnosis is to explore the use of biomarkers and 
molecular nucleic acid based detection. The challenge towards the application is that these 
target molecules often presence in very low quantities and small sizes, thus requires highly 
sensitive and specific measurement tools.  
SPR biosensors have shown immense potential for application in medical 
diagnostics, with the label-free capability and versatility to measure the interactions 
between biomolecules (including various disease biomarkers) and to provide the analysis 
in real time.3, 4 However, the main obstacle in achieving high sensitivity and specificity 
when measuring in real clinical samples has to do with the complexity of the biofluids.  
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In this dissertation, the overarching goal is to providing solutions in applying SPR 
biosensors into clinical setting via a design of smart and functional interfaces.  For this 
purpose, various surface modifications and biomolecular binding mechanisms were 
studied, intended to resolve the issues like the non-specific binding from complex media 
and the poor signal response from less effective interactions. In Chapter 2, the detection of 
P. falciparum DNA for early detection of Malaria using in-situ DNA hybridization chain 
reaction (HCR) and AuNPs signal amplification was demonstrated. A linear sensitivity 
range of target DNA concentrations from 0.1 nM to 0.1 μM was achieved and the signal 
was amplified 10x after AuNPs enhancement steps. The measurements were repeated in 
human blood plasma, the results showed that despite the non-specific binding from the 
plasma sample, the detection of target DNA was not compromised. Some limitations of 
this study include incomplete test of specificity against other Plasmodium species, and 
incomplete comparison in terms of sensitivity made to actual clinical methods such as PCR. 
Moving forward, these are the two areas that will be followed through, in addition to further 
work on a target DNA directly collected from Malaria patients. 
In Chapter 3, supported lipid bilayer membranes (SLBs) were introduced as an 
antifouling enabled sensitive detection of CT and IgG in undiluted human serum. The use 
of protein A not only provided a controlled orientation of capture antibody to specifically 
bind to the analytes, but the strong adsorption on EPC+ on protein A/MPO surface lead to 
a tightly packed structure that plays critical role for reduction of nonspecific binding. A 
linear sensitivity for CT concentration ranging from 5 to 25 µg/ml was achieved, and in the 
effort to further increase the sensitivity, the AuNPs enhancement step enabled detection at 
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lower concentrations, from 0.01 to 0.05 µg/ml of CT. The addition of this membrane 
caused no reduction in SPR signal when compared to a detection carried out via a 
traditional coupling scheme (i.e. EDC/NHS coupling over a mercaptoundecanoic acid). 
Although the FRAP analysis verified the strong charge-based interaction between EPC+ 
and protein A/MPO surface, it does not provide the information of the actual structure of 
the lipids formed on the surface. Therefore, more surface characterizations will be 
performed as future works.  
In Chapter 4, the potential of SPR for studying cancer cells toxicity was explored 
and the findings led to a more understanding of the complex cell-substrate interface. HeLa 
cells was chosen as model system, while H2O2 induced morphological changes to the cells 
with different behaviors as the concentrations of H2O2 increases. The theoretical equation 
that governed the effect of refractive index and adsorbed layer thickness to SPR signal has 
to be further expanded for the calculated signal to more precisely match the actual SPR 
signal. Other recommendations include improvement on the microscopic imaging 
technique, ideally the images of the actual cells on SPR chip used for the morphological 
observations. This can potentially be done by constructing an in-house high-resolution 
microscope camera attached to the SPR cell holder. Future work will be focused on 
studying more clinically relevant toxics or drugs related to cancer cells and treatment. 
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